| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | poly(U) RNA binding | HNRNPCL1 PABPC1L2A PABPC4 HNRNPCL3 PNPT1 HNRNPCL2 PABPC1 PABPC3 | 1.56e-08 | 34 | 275 | 8 | GO:0008266 |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | HNRNPCL1 PABPC1L2A PABPC4 HNRNPCL3 PNPT1 HNRNPCL2 PABPC1 PABPC3 | 4.97e-08 | 39 | 275 | 8 | GO:0008187 |
| GeneOntologyMolecularFunction | single-stranded RNA binding | HNRNPCL1 PABPC1L2A PABPC4 HNRNPCL3 PNPT1 HNRNPCL2 PABPC1 AGO1 PABPC3 AQR | 3.16e-06 | 111 | 275 | 10 | GO:0003727 |
| GeneOntologyMolecularFunction | deaminase binding | 1.02e-05 | 4 | 275 | 3 | GO:1990827 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1E CFTR SRP54 ABCA7 HELB STARD9 HFM1 KIF3C DNAH8 HSPA2 ABCG5 SLC27A6 KIF26B MSH5 MORC4 CCT6A ABCE1 MCM9 ATP1A3 HSPA14 XRCC6 AQR ACSL5 | 1.51e-05 | 614 | 275 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO1E CFTR SRP54 ABCA7 HELB HFM1 KIF3C DNAH8 HSPA2 ABCG5 MORC4 CCT6A ABCE1 MCM9 ATP1A3 HSPA14 XRCC6 AQR | 4.37e-05 | 441 | 275 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | poly-purine tract binding | 1.45e-04 | 37 | 275 | 5 | GO:0070717 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 1.89e-04 | 2 | 275 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 1.89e-04 | 2 | 275 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 1.89e-04 | 2 | 275 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 1.89e-04 | 2 | 275 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 3.21e-04 | 94 | 275 | 7 | GO:0050660 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 3.54e-04 | 25 | 275 | 4 | GO:0070034 | |
| GeneOntologyMolecularFunction | NAD binding | 5.08e-04 | 73 | 275 | 6 | GO:0051287 | |
| GeneOntologyMolecularFunction | adenosylhomocysteinase activity | 5.62e-04 | 3 | 275 | 2 | GO:0004013 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-sulfur bonds | 5.62e-04 | 3 | 275 | 2 | GO:0046508 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | NOLC1 PTTG1 HNRNPCL1 RPN2 SRP54 HNRNPCL3 TMCO1 HNRNPCL2 ABCE1 GEMIN4 | 5.96e-04 | 206 | 275 | 10 | GO:0043021 |
| GeneOntologyMolecularFunction | poly(A) binding | 6.37e-04 | 29 | 275 | 4 | GO:0008143 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 1.04e-03 | 15 | 275 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | myosin light chain kinase activity | 1.11e-03 | 4 | 275 | 2 | GO:0004687 | |
| GeneOntologyMolecularFunction | histone H3K36 dimethyltransferase activity | 1.11e-03 | 4 | 275 | 2 | GO:0140954 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 2.68e-06 | 90 | 269 | 9 | GO:0010833 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 7.29e-06 | 77 | 269 | 8 | GO:0007004 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.28e-05 | 83 | 269 | 8 | GO:0006278 | |
| GeneOntologyBiologicalProcess | telomere maintenance | PNKP HNRNPCL1 HNRNPCL3 PARP1 HNRNPCL2 TEP1 CCT6A ZNF827 TNKS2 RPA1 XRCC6 | 1.34e-05 | 168 | 269 | 11 | GO:0000723 |
| GeneOntologyBiologicalProcess | glutamine family amino acid catabolic process | 2.32e-05 | 27 | 269 | 5 | GO:0009065 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 3.21e-05 | 69 | 269 | 7 | GO:1904356 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 4.26e-05 | 6 | 269 | 3 | GO:0090367 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | ACADSB ETFA ETFDH DBT ALDH1L2 GLUD1 GLUD2 NOS1 GOT1 ACAD10 ARG2 HACL1 ACSL5 | 6.32e-05 | 272 | 269 | 13 | GO:0016054 |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | ACADSB ETFA ETFDH DBT ALDH1L2 GLUD1 GLUD2 NOS1 GOT1 ACAD10 ARG2 HACL1 ACSL5 | 6.32e-05 | 272 | 269 | 13 | GO:0046395 |
| GeneOntologyBiologicalProcess | telomere organization | PNKP HNRNPCL1 HNRNPCL3 PARP1 HNRNPCL2 TEP1 CCT6A ZNF827 TNKS2 RPA1 XRCC6 | 6.40e-05 | 199 | 269 | 11 | GO:0032200 |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 6.40e-05 | 33 | 269 | 5 | GO:1904357 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 7.39e-05 | 7 | 269 | 3 | GO:0090365 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome | 9.45e-05 | 140 | 269 | 9 | GO:0034502 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid catabolic process | 1.16e-04 | 20 | 269 | 4 | GO:0043649 | |
| GeneOntologyBiologicalProcess | glutamate catabolic process | 1.17e-04 | 8 | 269 | 3 | GO:0006538 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 1.29e-04 | 60 | 269 | 6 | GO:0032210 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | HK1 ACADSB GAPDH ETFA ETFDH DBT ALDH1L2 GLUD1 GLUD2 ALDH1A1 NOS1 GOT1 ACAD10 ARG2 HACL1 ACSL5 | 1.41e-04 | 421 | 269 | 16 | GO:0044282 |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 1.42e-04 | 61 | 269 | 6 | GO:0003254 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | PNKP HNRNPCL1 HNRNPCL3 PTK2B HROB HNRNPCL2 CHRAC1 TEP1 CCT6A TNKS2 RPA1 | 1.44e-04 | 218 | 269 | 11 | GO:0071897 |
| GeneOntologyBiologicalProcess | amino acid catabolic process | 1.51e-04 | 117 | 269 | 8 | GO:0009063 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.90e-04 | 121 | 269 | 8 | GO:0051899 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | PTTG1 PNKP HNRNPCL1 POGZ HNRNPCL3 HELB FANCA PTK2B PARP1 HROB PDS5A HFM1 TAF2 HNRNPCL2 REXO4 NSD2 CHAF1A MACROH2A1 MSH5 CHRAC1 TEP1 CCT6A ZNF827 FANCI EEPD1 MCM9 TNKS2 RPA1 XRCC6 | 1.93e-04 | 1081 | 269 | 29 | GO:0006259 |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 2.08e-04 | 42 | 269 | 5 | GO:0032205 | |
| GeneOntologyCellularComponent | sarcolemma | FER1L5 NOS1 VCL CACNA1C ANK1 ANK3 SLC27A6 LAMA2 PRKCE ATP1A3 AHNAK2 | 3.86e-05 | 190 | 270 | 11 | GO:0042383 |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 4.14e-05 | 6 | 270 | 3 | GO:1990826 | |
| GeneOntologyCellularComponent | adherens junction | MYO1E MTSS1 AJM1 TJP2 WNK3 VCL NPHP1 PARD3B SPTBN4 HMCN1 EPHA4 | 1.04e-04 | 212 | 270 | 11 | GO:0005912 |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 2.65e-04 | 97 | 270 | 7 | GO:0071013 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 2.78e-04 | 25 | 270 | 4 | GO:0005697 | |
| GeneOntologyCellularComponent | anchoring junction | MYLK MYO1E MTSS1 MPDZ ITGAV PTK2B AJM1 TJP2 KAZN IQGAP3 WNK3 VCL NPHP1 FLII ANK3 PARD3B PABPC1 LAP3 PRX SLC4A2 SPTBN4 SH3PXD2B HMCN1 SH3PXD2A PATJ EPHA4 | 4.03e-04 | 976 | 270 | 26 | GO:0070161 |
| GeneOntologyCellularComponent | mitochondrial electron transfer flavoprotein complex | 4.94e-04 | 3 | 270 | 2 | GO:0017133 | |
| GeneOntologyCellularComponent | electron transfer flavoprotein complex | 4.94e-04 | 3 | 270 | 2 | GO:0045251 | |
| GeneOntologyCellularComponent | T-tubule | 5.55e-04 | 79 | 270 | 6 | GO:0030315 | |
| GeneOntologyCellularComponent | DNA replication factor A complex | 6.98e-04 | 14 | 270 | 3 | GO:0005662 | |
| Domain | PDZ | STXBP4 MPDZ PTPN3 TJP2 NOS1 PDZD9 PARD3B RGS12 PRX PATJ AHNAK2 | 5.92e-06 | 141 | 267 | 11 | PF00595 |
| Domain | PDZ | STXBP4 MPDZ PTPN3 TJP2 NOS1 PDZD9 PARD3B RGS12 PRX PATJ AHNAK2 | 9.42e-06 | 148 | 267 | 11 | SM00228 |
| Domain | - | STXBP4 MPDZ PTPN3 TJP2 NOS1 PDZD9 PARD3B RGS12 PRX PATJ AHNAK2 | 1.07e-05 | 150 | 267 | 11 | 2.30.42.10 |
| Domain | PDZ | STXBP4 MPDZ PTPN3 TJP2 NOS1 PDZD9 PARD3B RGS12 PRX PATJ AHNAK2 | 1.14e-05 | 151 | 267 | 11 | PS50106 |
| Domain | PDZ | STXBP4 MPDZ PTPN3 TJP2 NOS1 PDZD9 PARD3B RGS12 PRX PATJ AHNAK2 | 1.21e-05 | 152 | 267 | 11 | IPR001478 |
| Domain | PolyA | 2.83e-05 | 5 | 267 | 3 | SM00517 | |
| Domain | PABP | 2.83e-05 | 5 | 267 | 3 | PF00658 | |
| Domain | PABC | 2.83e-05 | 5 | 267 | 3 | PS51309 | |
| Domain | - | 2.83e-05 | 5 | 267 | 3 | 1.10.1900.10 | |
| Domain | PABP_1234 | 2.83e-05 | 5 | 267 | 3 | IPR006515 | |
| Domain | PABP_HYD | 2.83e-05 | 5 | 267 | 3 | IPR002004 | |
| Domain | hnRNP_C | 5.60e-05 | 6 | 267 | 3 | IPR017347 | |
| Domain | UDENN | 6.49e-05 | 16 | 267 | 4 | PS50946 | |
| Domain | DDENN | 6.49e-05 | 16 | 267 | 4 | PS50947 | |
| Domain | dDENN | 6.49e-05 | 16 | 267 | 4 | SM00801 | |
| Domain | DENN | 6.49e-05 | 16 | 267 | 4 | SM00799 | |
| Domain | DENN | 6.49e-05 | 16 | 267 | 4 | PF02141 | |
| Domain | dDENN | 6.49e-05 | 16 | 267 | 4 | PF03455 | |
| Domain | dDENN_dom | 6.49e-05 | 16 | 267 | 4 | IPR005112 | |
| Domain | uDENN_dom | 6.49e-05 | 16 | 267 | 4 | IPR005113 | |
| Domain | DENN | 6.49e-05 | 16 | 267 | 4 | PS50211 | |
| Domain | DENN_dom | 6.49e-05 | 16 | 267 | 4 | IPR001194 | |
| Domain | ELFV_dehydrog_N | 2.04e-04 | 2 | 267 | 2 | PF02812 | |
| Domain | L27_2 | 2.04e-04 | 2 | 267 | 2 | PF09045 | |
| Domain | ELFV_dehydrog | 2.04e-04 | 2 | 267 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 2.04e-04 | 2 | 267 | 2 | IPR033922 | |
| Domain | ELFV_dehydrog | 2.04e-04 | 2 | 267 | 2 | SM00839 | |
| Domain | L27_2 | 2.04e-04 | 2 | 267 | 2 | IPR015132 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 2.04e-04 | 2 | 267 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 2.04e-04 | 2 | 267 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 2.04e-04 | 2 | 267 | 2 | IPR006095 | |
| Domain | GLFV_DEHYDROGENASE | 2.04e-04 | 2 | 267 | 2 | PS00074 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 2.04e-04 | 2 | 267 | 2 | IPR033524 | |
| Domain | ConA-like_dom | CLGN MDGA2 BTN2A2 HERC1 NPNT LAMA2 ADGRG6 EYS CELSR2 EGFLAM RNF39 | 3.27e-04 | 219 | 267 | 11 | IPR013320 |
| Domain | Laminin_G_1 | 4.38e-04 | 11 | 267 | 3 | PF00054 | |
| Domain | AdoHcyase_NAD | 6.05e-04 | 3 | 267 | 2 | SM00997 | |
| Domain | AdoHcyase | 6.05e-04 | 3 | 267 | 2 | SM00996 | |
| Domain | AdoHcyase_NAD | 6.05e-04 | 3 | 267 | 2 | PF00670 | |
| Domain | ADOHCYASE_1 | 6.05e-04 | 3 | 267 | 2 | PS00738 | |
| Domain | ADOHCYASE_2 | 6.05e-04 | 3 | 267 | 2 | PS00739 | |
| Domain | S-Ado-L-homoCys_hydrolase_CS | 6.05e-04 | 3 | 267 | 2 | IPR020082 | |
| Domain | Adenosylhomocysteinase | 6.05e-04 | 3 | 267 | 2 | IPR000043 | |
| Domain | AdoHcyase | 6.05e-04 | 3 | 267 | 2 | PF05221 | |
| Domain | Ado_hCys_hydrolase_NAD-bd | 6.05e-04 | 3 | 267 | 2 | IPR015878 | |
| Domain | uDENN | 9.36e-04 | 14 | 267 | 3 | SM00800 | |
| Domain | uDENN | 1.16e-03 | 15 | 267 | 3 | PF03456 | |
| Domain | PPR | 1.20e-03 | 4 | 267 | 2 | PF01535 | |
| Domain | Nucleotide-bd_a/b_plait | HNRNPCL1 PABPC1L2A PABPC4 DGKQ MYEF2 R3HCC1L HNRNPCL4 TDRD10 HNRNPCL2 PABPC1 PABPC3 | 1.27e-03 | 258 | 267 | 11 | IPR012677 |
| Pubmed | NOLC1 EFCAB5 AHCYL1 DENND4A HNRNPCL1 HK1 MYLK RPN2 PABPC4 HNRNPCL3 PARP1 C6orf118 BBX STXBP2 STARD9 GLUD1 GLUD2 VPS13A ALDH1A1 TMCO1 DNAH8 MLPH HSPA2 HNRNPCL2 AMIGO2 SLC17A6 BAHCC1 PLXNA3 CACNA1C RANGAP1 COPA PCDHGB1 NSD2 PCDHGA7 CHAF1A UBR4 MACROH2A1 AHCYL2 SRBD1 PABPC1 PRX MYLK2 SPTBN4 CCT6A BRD2 SH3PXD2A PABPC3 DNAJC11 UGGT2 ATP1A3 PCDHGA8 XRCC6 EPHA4 | 8.70e-21 | 1442 | 277 | 53 | 35575683 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 DENND4A HK1 RRP1B GAPDH RPN2 PABPC4 KIAA0586 ETFA POGZ DBT NDUFV1 JARID2 PARP1 STARD9 UBTF GLUD1 MKI67 PDS5A PUM3 KIF3C UQCRC1 IQGAP3 RASAL2 VCL FLII RANGAP1 REXO4 COPA TCOF1 NSD2 CHAF1A UBR4 LRRC40 MACROH2A1 PABPC1 LAP3 CCT6A GTF2I ABCE1 FANCI DNAJC11 GEMIN4 GALNT5 RPA1 CPSF3 XRCC6 AQR | 2.45e-17 | 1425 | 277 | 48 | 30948266 |
| Pubmed | NOLC1 HK1 RRP1B RPN2 PABPC4 POGZ MYEF2 PNPT1 SBF1 UBTF MKI67 TJP2 PDS5A PUM3 UQCRC1 HSPA2 VCL RANGAP1 REXO4 COPA TCOF1 NSD2 UBR4 NSD1 PABPC1 GTF2I ABCE1 FANCI GEMIN4 CPSF3 XRCC6 AQR | 3.12e-16 | 653 | 277 | 32 | 22586326 | |
| Pubmed | EPHB4 NOLC1 AHCYL1 HK1 ACADSB RRP1B RPN2 DNAJC19 STXBP4 ETFA MPDZ SRP54 DBT NDUFV1 PNPT1 PARP1 R3HCC1L SBF1 P3H1 UBTF GLUD1 VPS13A HSPA2 RASAL2 VCL RANGAP1 ANK3 TCOF1 UBR4 LRRC40 MACROH2A1 E2F6 AIP RAB11FIP1 SLC4A2 PREB WDR74 FAM193A BRD2 DNAJC11 UGGT2 HSPA14 XRCC6 AQR | 5.96e-14 | 1487 | 277 | 44 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 AHCYL1 HK1 GAPDH SRP54 POGZ MYEF2 PARP1 AP3S1 SBF1 UBTF MKI67 PDS5A PUM3 UQCRC1 TAF2 RASAL2 VCL FLII RANGAP1 REXO4 COPA UBR4 OAS3 LRRC40 MACROH2A1 SRBD1 PABPC1 PLCD3 WDR74 CCT6A GTF2I UPF2 ABCE1 FANCI GEMIN4 RPA1 CPSF3 XRCC6 AQR AHNAK2 | 2.22e-13 | 1353 | 277 | 41 | 29467282 |
| Pubmed | NOLC1 ASXL1 AHCYL1 ZNF609 RRP1B RPN2 PABPC4 IRF4 POGZ DBT HNF4A MEF2D BBX ALMS1 UBTF GLUD1 ARID5B MKI67 PDS5A PUM3 PPIL2 UQCRC1 TAF2 HERC1 VCL REXO4 COPA UBR4 E2F6 MORC4 PABPC1 CCT6A GTF2I AGO1 BRD2 ZFHX4 PABPC3 RPA1 XRCC6 SP7 | 5.32e-12 | 1429 | 277 | 40 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 ZNF609 HNRNPCL1 RRP1B GAPDH PABPC4 POGZ MEF2D HNRNPCL3 PARP1 BBX UBTF MKI67 PDS5A PUM3 UQCRC1 HSPA2 HNRNPCL2 RANGAP1 REXO4 NSD2 CHAF1A NSD1 MACROH2A1 ZDBF2 PABPC1 GTF2I BRD2 FANCI PABPC3 PPIAL4G XRCC6 | 9.08e-12 | 954 | 277 | 32 | 36373674 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GAPDH CSMD2 PCDH17 FANCA SLC38A10 AP3S1 R3HCC1L P3H1 VPS13A ARID5B PDS5A KAZN ARHGAP20 RANGAP1 REXO4 ANK1 KIF26B COL28A1 UBR4 OR52L1 ZNF316 LRRC40 PRR35 ABCE1 RPA1 XRCC6 SP7 | 5.88e-11 | 736 | 277 | 27 | 29676528 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 DENND4A STXBP4 MPDZ MEF2D ENKD1 PTK2B PTPN3 ALMS1 SBF1 STARD9 TJP2 WNK3 RASAL2 KIF26B PARD3B STK32C RAB11FIP1 PABPC1 RGS12 DENND4C MYLK2 SH3PXD2B SH3PXD2A PRKCE PATJ AQR AHNAK2 | 3.95e-10 | 861 | 277 | 28 | 36931259 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CPNE2 NOLC1 MYO1E RRP1B GAPDH RPN2 PABPC4 DBT PARP1 PTPN3 UBTF GLUD1 MKI67 TJP2 PUM3 IQGAP3 RASAL2 FLII REXO4 COPA OAS3 MACROH2A1 SRBD1 PABPC1 WDR74 CCT6A GTF2I UPF2 DNAJC11 GEMIN4 PATJ HSPA14 XRCC6 AQR | 5.92e-10 | 1257 | 277 | 34 | 36526897 |
| Pubmed | AHCYL1 GAPDH RPN2 PABPC4 MPDZ PARP1 AP3S1 PDS5A RASAL2 VCL RANGAP1 ANK3 COPA TCOF1 LRRC40 PABPC1 DENND4C PREB CCT6A ABCE1 FANCI GEMIN4 PATJ RPA1 XRCC6 | 6.84e-10 | 708 | 277 | 25 | 39231216 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HK1 GAPDH PABPC4 ETFA MPDZ PHKA1 PARP1 STXBP2 GLUD1 PDS5A HSPA2 IQGAP3 GOT1 VCL FLII RANGAP1 ANK3 COPA TCOF1 UBR4 AIP MORC4 PABPC1 LAP3 GSS CCT6A GTF2I FANCI GEMIN4 PATJ RPA1 XRCC6 | 9.74e-10 | 1149 | 277 | 32 | 35446349 |
| Pubmed | NOLC1 AHCYL1 PNKP ZNF609 ACADSB RRP1B GAPDH RPN2 PABPC4 ETFA DBT MEF2D PNPT1 PARP1 GLUD1 MKI67 PPIL2 VCL ANKRD35 FLII RANGAP1 COPA TCOF1 PABPC1 CCT6A ABCE1 DNAJC11 INAVA ATP1A3 PATJ RPA1 XRCC6 AQR | 1.86e-09 | 1247 | 277 | 33 | 27684187 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 HNRNPCL1 MYO1E RRP1B GAPDH PABPC4 HNRNPCL3 PARP1 UBTF MKI67 HNRNPCL4 PPIL2 TAF2 HSPA2 HNRNPCL2 FLII RANGAP1 COPA TCOF1 MACROH2A1 PABPC1 PLCD3 CCT6A GTF2I GEMIN4 RPA1 CPSF3 XRCC6 | 3.38e-09 | 949 | 277 | 28 | 36574265 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NOLC1 HK1 ACADSB RRP1B ETFA SRP54 DBT NDUFV1 PNPT1 PARP1 ALMS1 ALDH1L2 GLUD1 VPS13A UQCRC1 HERC1 TMCO1 MTRF1L FLII COPA UBR4 LRRC40 MACROH2A1 ZDBF2 AHCYL2 AIP ARG2 PREB CCT6A UPF2 ABCE1 DNAJC11 GEMIN4 RPA1 XRCC6 AHNAK2 | 3.94e-09 | 1496 | 277 | 36 | 32877691 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 MYO1E RPN2 PABPC4 SRP54 POGZ SBF1 MKI67 TJP2 PPIL2 TAF2 TMCO1 VCL FLII RANGAP1 REXO4 COPA PABPC1 SH3PXD2B AGO1 FAM193A UPF2 SH3PXD2A AHNAK2 | 5.21e-09 | 724 | 277 | 24 | 36232890 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 MYO1E DGKQ ATG2A ABCA7 FANCA SLC38A10 SBF1 HERC1 IQGAP3 BAHCC1 PLXNA3 FLII NSD2 UBR4 ZNF316 NSD1 STK32C TEP1 LDLR PLCD3 SH3PXD2B BRD2 CELSR2 ZNF827 FANCI ZNF335 PKN1 AHNAK2 PPP1R16A | 6.04e-09 | 1105 | 277 | 30 | 35748872 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 HNRNPCL1 HK1 RRP1B RPN2 SRP54 POGZ DBT NDUFV1 MYEF2 PNPT1 PARP1 BBX SBF1 PDS5A PPIL2 RANGAP1 REXO4 COPA TCOF1 NSD2 MACROH2A1 CCT6A AGO1 BRD2 UPF2 CPSF3 XRCC6 AQR | 1.46e-08 | 1082 | 277 | 29 | 38697112 |
| Pubmed | AHCYL1 HNRNPCL1 HK1 MYO1E GAPDH PABPC4 NDUFV1 MYEF2 HNRNPCL3 PTK2B PARP1 SBF1 AJM1 GLUD1 GLUD2 TJP2 UQCRC1 NOS1 HSPA2 GOT1 HNRNPCL2 RASAL2 VCL FLII ANK3 COPA PABPC1 SPTBN4 CCT6A AGO1 UPF2 PABPC3 PRKCE ATP1A3 | 1.52e-08 | 1431 | 277 | 34 | 37142655 | |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 1.58e-08 | 37 | 277 | 7 | 36835656 | |
| Pubmed | AHCYL1 DENND4A ZNF609 HNRNPCL1 RPN2 MPDZ HNRNPCL3 FANCA SBF1 HNRNPCL4 TMCO1 CLEC16A IQGAP3 RASAL2 SLC4A2 PREB PLCD3 UPF2 ABCE1 UGGT2 PATJ AQR | 1.61e-08 | 650 | 277 | 22 | 38777146 | |
| Pubmed | PNKP HNRNPCL1 MYO1E GAPDH PABPC4 PARP1 BBX PDS5A COPA TCOF1 SRBD1 PABPC1 GTF2I GEMIN4 RPA1 XRCC6 | 1.81e-08 | 340 | 277 | 16 | 24332808 | |
| Pubmed | MYO1E ACADSB RRP1B GAPDH PABPC4 ETFA SRP54 POGZ ITGAV PNPT1 PARP1 STARD9 MKI67 TJP2 PUM3 WIPF2 FLII REXO4 COPA TCOF1 OAS3 LRRC40 MACROH2A1 AIP PABPC1 WDR74 GTF2I UPF2 PCSK6 GEMIN4 RPA1 HSPA14 XRCC6 | 1.85e-08 | 1371 | 277 | 33 | 36244648 | |
| Pubmed | NOLC1 RRP1B GAPDH PARP1 UBTF MKI67 UQCRC1 HSPA2 FLII COPA TCOF1 NSD2 MACROH2A1 PABPC1 CCT6A BRD2 ABCE1 XRCC6 | 2.07e-08 | 441 | 277 | 18 | 31239290 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 RRP1B GAPDH RPN2 PABPC4 ETFA DBT PARP1 AP3S1 STXBP2 GLUD1 MKI67 TJP2 ANK1 COPA TCOF1 CHAF1A UBR4 LRRC40 MACROH2A1 PABPC1 LAP3 WDR74 CCT6A GTF2I UPF2 ABCE1 DNAJC11 RPA1 CPSF3 XRCC6 AQR | 2.54e-08 | 1318 | 277 | 32 | 30463901 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZNF609 POGZ PARP1 ARID5B HSPA2 GOT1 BAHCC1 FLII LRRC40 MACROH2A1 MORC4 BRD2 ZFHX4 GEMIN4 TNKS2 RPA1 MVK | 2.67e-08 | 398 | 277 | 17 | 35016035 |
| Pubmed | AHCYL1 RRP1B GAPDH RPN2 PARP1 P3H1 WNK3 GOT1 VCL AHCYL2 PABPC1 CCT6A GTF2I ABCE1 PABPC3 DNAJC11 RPA1 XRCC6 | 2.91e-08 | 451 | 277 | 18 | 36168627 | |
| Pubmed | Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. | 3.77e-08 | 25 | 277 | 6 | 15385968 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | PNKP HNRNPCL1 HNRNPCL3 PARP1 P3H1 GLUD1 GLUD2 UQCRC1 ALDH1A1 GOT1 HNRNPCL2 TCOF1 XRCC6 | 3.93e-08 | 226 | 277 | 13 | 37839992 |
| Pubmed | PNKP RRP1B SLC39A11 PABPC4 MPDZ SRP54 NDUFV1 MYEF2 JARID2 BBX SBF1 PDS5A PUM3 UQCRC1 TAF2 TMCO1 IQGAP3 REXO4 NSD2 CHAF1A NSD1 WHAMM ZNF385A SRBD1 RAB11FIP1 MYLK2 PREB PLCD3 CCT6A BRD2 DNAJC11 GEMIN4 PATJ AQR | 4.50e-08 | 1497 | 277 | 34 | 31527615 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPHB4 CLGN RPN2 NDUFV1 FANCA P3H1 PDS5A PPIL2 TMCO1 HSPA2 IQGAP3 WNK3 RANGAP1 COPA TCOF1 UBR4 LRRC40 SLC4A2 PREB FANCI PCSK6 DNAJC11 GEMIN4 UGGT2 ATP1A3 HSPA14 | 4.78e-08 | 942 | 277 | 26 | 31073040 |
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 5.83e-08 | 6 | 277 | 4 | 1317320 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 PNKP RRP1B VPS33A POGZ BBX UBTF MKI67 TAF2 TMCO1 NOVA2 FLII NSD2 CHAF1A NSD1 MACROH2A1 E2F6 GTF2I BRD2 | 7.07e-08 | 533 | 277 | 19 | 30554943 |
| Pubmed | HK1 ACADSB GAPDH ETFA ETFDH DBT NDUFV1 PNPT1 GLUD1 GLUD2 UQCRC1 VCL ANK3 LAMA2 ACAD10 | 8.31e-08 | 331 | 277 | 15 | 29199018 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HK1 ACADSB GAPDH RPN2 PABPC4 VPS33A ETFA PARP1 GLUD1 GLUD2 TMCO1 HSPA2 IQGAP3 FLII RANGAP1 COPA UBR4 MORC4 PABPC1 PREB CCT6A GTF2I ABCE1 FANCI PABPC3 DNAJC11 GEMIN4 RPA1 CPSF3 XRCC6 | 1.04e-07 | 1257 | 277 | 30 | 37317656 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RRP1B POGZ PARP1 BBX UBTF MKI67 PDS5A PUM3 PPIL2 TAF2 REXO4 NSD2 CHAF1A NSD1 SRBD1 GTF2I BRD2 FANCI RPA1 XRCC6 | 1.16e-07 | 608 | 277 | 20 | 36089195 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 RRP1B GAPDH RPN2 PARP1 UBTF MKI67 PUM3 PPIL2 UQCRC1 VCL REXO4 COPA TCOF1 CHAF1A MACROH2A1 SRBD1 LAP3 WDR74 CCT6A GTF2I BRD2 FANCI RPA1 CPSF3 XRCC6 | 1.24e-07 | 989 | 277 | 26 | 36424410 |
| Pubmed | DENND4A KIAA0586 MPDZ SRP54 HELB ALMS1 RASAL2 VCL KIF26B ZDBF2 DENND4C FAM193A | 1.34e-07 | 209 | 277 | 12 | 36779422 | |
| Pubmed | 1.48e-07 | 103 | 277 | 9 | 32744500 | ||
| Pubmed | NOLC1 AHCYL1 GAPDH VPS33A ETFA DBT NDUFV1 MYEF2 AP3S1 AJM1 GLUD1 GLUD2 TJP2 NOS1 HSPA2 CLEC16A FLII RANGAP1 ANK3 UBR4 MACROH2A1 ZDBF2 AHCYL2 PREB CCT6A CELSR2 ABCE1 DNAJC11 | 1.56e-07 | 1139 | 277 | 28 | 36417873 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 PNKP ZNF609 RRP1B RPN2 DNAJC19 POGZ FANCA PARP1 BBX UBTF ARID5B MKI67 PDS5A RANGAP1 COPA TCOF1 NSD2 CHAF1A NSD1 E2F6 CHRAC1 SRBD1 LDLR PREB GTF2I BRD2 RPA1 CPSF3 XRCC6 | 1.93e-07 | 1294 | 277 | 30 | 30804502 |
| Pubmed | ACADSB VPS33A ETFA CSMD2 MYEF2 VPS13A ARID5B HFM1 TAF2 FER1L5 UTY MAML3 RASAL2 TRAPPC11 UBR4 ZDBF2 MORC4 ABCE1 LPO AHNAK2 | 2.50e-07 | 638 | 277 | 20 | 31182584 | |
| Pubmed | MPDZ MYEF2 PARP1 SBF1 NOS1 WNK3 RASAL2 FLII RANGAP1 ANK3 TCOF1 UBR4 NSD1 MACROH2A1 PABPC1 SPTBN4 SH3PXD2B AGO1 CELSR2 PABPC3 PRKCE PKN1 RPA1 XRCC6 EPHA4 | 2.76e-07 | 963 | 277 | 25 | 28671696 | |
| Pubmed | RRP1B GAPDH PABPC4 UBTF FLII RANGAP1 COPA TCOF1 OAS3 SRBD1 PABPC1 CCT6A GTF2I AGO1 CPSF3 XRCC6 AQR | 2.77e-07 | 469 | 277 | 17 | 37314180 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | NOLC1 PNKP RRP1B GAPDH PABPC4 SRP54 DBT NDUFV1 MYEF2 PARP1 GLUD1 UQCRC1 RANGAP1 REXO4 ZNF385A PABPC1 LAP3 GSS CCT6A HSPA14 XRCC6 | 2.81e-07 | 704 | 277 | 21 | 32994395 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | HK1 SRP54 AP3S1 STXBP2 PDS5A PUM3 UQCRC1 TMCO1 DNAH8 IQGAP3 FLII TRAPPC11 RANGAP1 COPA UBR4 LAP3 CCT6A UPF2 ABCE1 RPA1 HSPA14 | 2.81e-07 | 704 | 277 | 21 | 29955894 |
| Pubmed | RRP1B PABPC4 MPDZ PARP1 TJP2 FLII RANGAP1 PABPC1 GTF2I AGO1 PATJ RPA1 CPSF3 | 3.65e-07 | 274 | 277 | 13 | 34244482 | |
| Pubmed | ZNF609 RRP1B RPN2 STXBP4 DBT PHKA1 PARP1 PTPN3 SBF1 P3H1 UBTF VPS13A MKI67 HERC1 HSPA2 RANGAP1 ANK3 COPA NSD2 GPRIN3 AIP RAB11FIP1 BRD2 FANCI RPA1 CPSF3 | 3.81e-07 | 1049 | 277 | 26 | 27880917 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | CHDH SLC38A10 UBTF GLUD1 GLUD2 HERC1 HSPA2 COPA BRD2 ABCE1 GEMIN4 RPA1 | 3.95e-07 | 231 | 277 | 12 | 36597993 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | NOLC1 AHCYL1 RRP1B PABPC4 PHKA1 PARP1 GLUD1 RASAL2 TCOF1 AHCYL2 AIP CCT6A BRD2 ABCE1 FANCI PATJ | 4.70e-07 | 432 | 277 | 16 | 23455922 |
| Pubmed | HK1 ACADSB GAPDH RPN2 ETFA ETFDH ITGAV NDUFV1 HELB PNPT1 PARP1 STXBP2 P3H1 GLUD1 UQCRC1 DNAH8 HSPA2 GOT1 TCOF1 LAP3 PREB DNAJC11 XRCC6 | 4.97e-07 | 859 | 277 | 23 | 31536960 | |
| Pubmed | 5.00e-07 | 3 | 277 | 3 | 29861105 | ||
| Pubmed | 5.00e-07 | 3 | 277 | 3 | 21940797 | ||
| Pubmed | 5.00e-07 | 3 | 277 | 3 | 36640309 | ||
| Pubmed | HK1 ACADSB GAPDH DNAJC19 ETFA ETFDH DBT NDUFV1 PNPT1 GLUD1 GLUD2 UQCRC1 ACAD10 LAP3 DNAJC11 | 5.19e-07 | 382 | 277 | 15 | 29222160 | |
| Pubmed | NOLC1 PNKP CLGN HK1 MYO1E ACADSB RRP1B RPN2 PABPC4 ETFA PARP1 AP3S1 UBTF MKI67 TJP2 PDS5A PUM3 UQCRC1 HSPA2 RANGAP1 COPA UBR4 OAS3 ARG2 CCT6A GTF2I FANCI GEMIN4 RPA1 XRCC6 AHNAK2 | 5.86e-07 | 1440 | 277 | 31 | 30833792 | |
| Pubmed | EPHB4 RRP1B GAPDH RPN2 PABPC4 VPS33A SRP54 ITGAV NDUFV1 PARP1 P3H1 MKI67 PDS5A UQCRC1 TMCO1 COPA TCOF1 UBR4 AIP RAB11FIP1 PABPC1 LDLR CCT6A HACL1 UGGT2 RPA1 CPSF3 XRCC6 AQR | 6.52e-07 | 1297 | 277 | 29 | 33545068 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HK1 GAPDH RPN2 VPS33A ETFA MYEF2 PARP1 TDRD10 UQCRC1 ALDH1A1 HSPA2 IQGAP3 VCL ANK3 COPA UBR4 GPRIN3 PABPC1 CCT6A ABCE1 XRCC6 AHNAK2 | 6.60e-07 | 807 | 277 | 22 | 30575818 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CPNE2 HNRNPCL1 HK1 GAPDH NDUFV1 HNRNPCL3 PTK2B GLUD1 GLUD2 UQCRC1 ALDH1A1 NOS1 HSPA2 HNRNPCL2 ANK1 PABPC1 CCT6A PABPC3 PRKCE | 7.23e-07 | 621 | 277 | 19 | 22794259 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | HNRNPCL1 HNRNPCL3 PARP1 STXBP2 GLUD1 GLUD2 HNRNPCL2 VCL COPA UBR4 OAS3 PABPC1 SH3PXD2B PABPC3 | 8.19e-07 | 344 | 277 | 14 | 30333137 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 RRP1B GAPDH PABPC4 ETFA MYEF2 PARP1 STXBP2 UBTF GLUD1 MKI67 TJP2 PUM3 FLII RANGAP1 COPA TCOF1 LRRC40 MACROH2A1 PABPC1 CCT6A BRD2 RPA1 XRCC6 AQR | 8.47e-07 | 1024 | 277 | 25 | 24711643 |
| Pubmed | Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. | NDUFV1 GLUD1 GLUD2 UQCRC1 GOT1 AHCYL2 PABPC1 LAP3 PABPC3 PRKCE | 9.74e-07 | 166 | 277 | 10 | 27160897 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | RRP1B RPN2 PABPC4 DBT PTPN3 GLUD1 MKI67 HERC1 FLII UBR4 CCT6A GTF2I AGO1 FANCI GEMIN4 RPA1 XRCC6 PPP1R16A | 9.81e-07 | 573 | 277 | 18 | 28330616 |
| Pubmed | NOLC1 ZNF609 POGZ DBT ABCA7 ENKD1 MYEF2 AP3S1 ALMS1 TAF2 NOVA2 BAHCC1 TCOF1 NSD2 CHAF1A ZNF316 OAS3 MACROH2A1 RAB11FIP1 TEP1 LDLR ARG2 BRD2 ZFHX4 ZNF827 PCSK6 | 1.21e-06 | 1116 | 277 | 26 | 31753913 | |
| Pubmed | NOLC1 PABPC4 HELB JARID2 ALMS1 UBTF PDS5A TAF2 CHAF1A PARD3B MORC4 CCDC141 CCT6A BRD2 FANCI AQR | 1.38e-06 | 469 | 277 | 16 | 27634302 | |
| Pubmed | CPNE2 NOLC1 HNRNPCL1 GAPDH RPN2 PABPC4 GLUD1 GLUD2 MKI67 UQCRC1 TMCO1 HSPA2 ANK3 UBR4 PABPC1 CCT6A AGO1 HMCN1 ABCE1 PABPC3 RPA1 XRCC6 | 1.38e-06 | 844 | 277 | 22 | 25963833 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | GAPDH PABPC4 ETFA MYEF2 HNRNPCL3 PARP1 GLUD1 MKI67 TJP2 PUM3 UQCRC1 HSPA2 GOT1 MACROH2A1 PABPC1 CCT6A RPA1 CPSF3 XRCC6 AQR | 1.43e-06 | 714 | 277 | 20 | 28302793 |
| Pubmed | NOLC1 HNRNPCL1 GAPDH POGZ FANCA PARP1 MKI67 PDS5A PUM3 UQCRC1 RANGAP1 TCOF1 CHAF1A MACROH2A1 RAB11FIP1 PABPC1 GTF2I FANCI XRCC6 | 1.48e-06 | 652 | 277 | 19 | 31180492 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF609 RRP1B GAPDH RPN2 SLC39A11 POGZ ITGAV PARP1 AP3S1 ARID5B MKI67 PDS5A TAF2 TMCO1 NOVA2 AMIGO2 RANGAP1 TCOF1 ZNF316 MACROH2A1 LDLR PREB WDR74 FANCI GEMIN4 AQR ACSL5 | 1.51e-06 | 1203 | 277 | 27 | 29180619 |
| Pubmed | NOLC1 HNRNPCL1 PABPC4 MPDZ P3H1 WIPF2 PABPC1 PREB CCT6A PABPC3 CPSF3 | 1.75e-06 | 220 | 277 | 11 | 24550385 | |
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 1.99e-06 | 4 | 277 | 3 | 35729324 | |
| Pubmed | 1.99e-06 | 4 | 277 | 3 | 36681355 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 1.99e-06 | 4 | 277 | 3 | 10805751 | |
| Pubmed | 1.99e-06 | 4 | 277 | 3 | 23831410 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 GAPDH STXBP4 ETFA SRP54 PARP1 R3HCC1L ALMS1 UBTF GLUD1 MKI67 VCL RANGAP1 TCOF1 MACROH2A1 PABPC1 GTF2I FAM193A ABCE1 RPA1 CPSF3 XRCC6 AHNAK2 | 2.05e-06 | 934 | 277 | 23 | 33916271 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NOLC1 AHCYL1 HK1 MYO1E GAPDH PABPC4 ETFA AP3S1 P3H1 TJP2 HERC1 GOT1 VCL FLII RANGAP1 COPA UBR4 AIP CHRAC1 PABPC1 LAP3 GSS CCT6A GTF2I ABCE1 FANCI RPA1 XRCC6 MVK AHNAK2 | 2.16e-06 | 1455 | 277 | 30 | 22863883 |
| Pubmed | ASXL1 PABPC4 PARP1 SBF1 SLC29A4 ANK1 COPA NSD2 NSD1 LDLR SH3PXD2B EYS AHNAK2 | 3.10e-06 | 332 | 277 | 13 | 37433992 | |
| Pubmed | AHCYL1 ZNF609 VPS33A SRP54 MYEF2 ARID5B TAF2 IQGAP3 RANGAP1 UBR4 ZDBF2 ZFHX4 | 3.19e-06 | 282 | 277 | 12 | 23667531 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | NOLC1 PABPC4 ETFA DBT HSPA2 RANGAP1 LRRC40 PABPC1 WDR74 RPA1 CPSF3 XRCC6 | 3.31e-06 | 283 | 277 | 12 | 28533407 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 RRP1B PABPC4 DBT UBTF MKI67 PUM3 IQGAP3 FLII REXO4 COPA NSD2 MACROH2A1 SRBD1 WDR74 UPF2 MCM9 HSPA14 XRCC6 AQR | 3.59e-06 | 759 | 277 | 20 | 35915203 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 MYO1E RRP1B GAPDH RPN2 DNAJC19 PABPC4 PNPT1 PARP1 AP3S1 GLUD1 PDS5A PPIL2 FLII RANGAP1 COPA TCOF1 UBR4 LRRC40 AHCYL2 PABPC1 LDLR CCT6A GTF2I GEMIN4 HSPA14 XRCC6 AQR AHNAK2 | 3.63e-06 | 1415 | 277 | 29 | 28515276 |
| Pubmed | MYO1E PABPC4 PARP1 FLII COPA OAS3 PABPC1 PLCD3 GTF2I INAVA RPA1 XRCC6 | 3.68e-06 | 286 | 277 | 12 | 32041737 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 3.94e-06 | 152 | 277 | 9 | 28192407 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | CPNE2 HNRNPCL1 GAPDH RPN2 PARP1 HSPA2 PABPC1 CCT6A GTF2I PABPC3 RPA1 XRCC6 | 3.96e-06 | 288 | 277 | 12 | 31501420 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 POGZ MYEF2 MKI67 PDS5A RANGAP1 TCOF1 UBR4 SRBD1 UPF2 FANCI GEMIN4 AQR | 4.14e-06 | 341 | 277 | 13 | 32971831 |
| Pubmed | HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. | 4.94e-06 | 5 | 277 | 3 | 19956697 | |
| Pubmed | 4.94e-06 | 5 | 277 | 3 | 29846695 | ||
| Pubmed | 4.94e-06 | 5 | 277 | 3 | 33744966 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 4.94e-06 | 5 | 277 | 3 | 25809670 | |
| Pubmed | 4.94e-06 | 5 | 277 | 3 | 9128719 | ||
| Pubmed | NOLC1 HK1 GAPDH PABPC4 PTPN3 AP3S1 BBX VPS13A MKI67 TJP2 PDS5A CLEC16A RASAL2 REXO4 ANK3 TCOF1 GPRIN3 CCT6A GTF2I PKN1 | 5.07e-06 | 777 | 277 | 20 | 35844135 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NOLC1 HK1 RRP1B GAPDH RPN2 ETFA SRP54 PARP1 AP3S1 GLUD1 TJP2 VCL RANGAP1 COPA TCOF1 UBR4 OAS3 MACROH2A1 PABPC1 LAP3 GSS CCT6A SH3PXD2B ABCE1 CPSF3 XRCC6 MVK AHNAK2 | 5.45e-06 | 1367 | 277 | 28 | 32687490 |
| Pubmed | NOLC1 CLGN RRP1B GAPDH RPN2 PABPC4 ETFA PARP1 MKI67 FLII COPA MACROH2A1 PABPC1 CCT6A XRCC6 | 5.51e-06 | 463 | 277 | 15 | 34901782 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | AHCYL1 ZNF609 GAPDH POGZ DBT ALMS1 GLUD1 ARID5B MKI67 BAHCC1 E2F6 MORC4 ZFHX4 | 5.66e-06 | 351 | 277 | 13 | 38297188 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | AHCYL1 GAPDH RPN2 ETFA ETFDH DBT ITGAV NDUFV1 PNPT1 SLC38A10 SBF1 ALDH1L2 P3H1 AJM1 GLUD1 GLUD2 KIF3C UQCRC1 TMCO1 ANKRD35 COPA OAS3 ACAD10 PABPC1 SLC4A2 CELSR2 PABPC3 UGGT2 ACSL5 | 5.87e-06 | 1451 | 277 | 29 | 30550785 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | EPHB4 AHCYL1 ZNF609 FANCA PTPN3 SLC38A10 P3H1 UBTF HERC1 MLPH RASAL2 PARD3B RAB11FIP1 RGS12 DENND4C EVA1C GALNT5 HSPA14 PPP1R16A | 6.06e-06 | 719 | 277 | 19 | 35337019 |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 7.70e-06 | 125 | 277 | 8 | 21654808 | |
| Pubmed | NOLC1 PNKP SRP54 PARP1 UBTF MKI67 PDS5A TAF2 COPA NSD2 CHAF1A UBR4 MACROH2A1 AIP CCT6A GTF2I BRD2 ABCE1 FANCI RPA1 CPSF3 XRCC6 AQR | 7.87e-06 | 1014 | 277 | 23 | 32416067 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 7.99e-06 | 210 | 277 | 10 | 26217791 | |
| Pubmed | HK1 ACADSB GAPDH ETFA ETFDH DBT NDUFV1 GLUD1 GLUD2 UQCRC1 HSPA2 DMGDH ACAD10 LAP3 ARG2 ACSL5 | 8.62e-06 | 542 | 277 | 16 | 14651853 | |
| Interaction | CIT interactions | NOLC1 PNKP CLGN MYO1E RRP1B GAPDH RPN2 STXBP4 PABPC4 ETFA SRP54 POGZ BFSP1 HNRNPCL3 ALMS1 UBTF GLUD1 MKI67 TJP2 HNRNPCL4 PDS5A PUM3 UQCRC1 HERC1 TMCO1 HSPA2 HNRNPCL2 RASAL2 ANKRD35 RANGAP1 COPA TCOF1 CHAF1A UBR4 OAS3 HEATR5A MACROH2A1 E2F6 SRBD1 PABPC1 SPTBN4 CCT6A GTF2I CELSR2 FANCI PABPC3 PATJ XRCC6 AQR AHNAK2 | 6.87e-10 | 1450 | 272 | 50 | int:CIT |
| Interaction | SIRT7 interactions | NOLC1 HK1 RRP1B RPN2 PABPC4 POGZ MYEF2 PNPT1 SBF1 UBTF MKI67 TJP2 PDS5A PUM3 UQCRC1 HSPA2 VCL RANGAP1 REXO4 COPA TCOF1 NSD2 UBR4 NSD1 PABPC1 GTF2I ABCE1 FANCI GEMIN4 CPSF3 XRCC6 AQR | 7.71e-09 | 744 | 272 | 32 | int:SIRT7 |
| Interaction | BIRC3 interactions | NOLC1 DENND4A HK1 RRP1B GAPDH RPN2 KIAA0586 ETFA POGZ DBT NDUFV1 JARID2 PARP1 STARD9 UBTF GLUD1 MKI67 PDS5A KIF3C UQCRC1 RASAL2 VCL FLII RANGAP1 REXO4 COPA TCOF1 CHAF1A UBR4 MACROH2A1 PABPC1 LAP3 CCT6A GTF2I ABCE1 FANCI DNAJC11 GEMIN4 GALNT5 RPA1 CPSF3 XRCC6 AQR | 8.97e-08 | 1334 | 272 | 43 | int:BIRC3 |
| Interaction | PIP4K2A interactions | NOLC1 AHCYL1 RRP1B AP3S1 SBF1 UBTF GLUD1 TAF2 TCOF1 ST6GAL1 AHCYL2 RAB11FIP1 PLCD3 BRD2 RPA1 | 2.63e-07 | 216 | 272 | 15 | int:PIP4K2A |
| Interaction | SMC5 interactions | NOLC1 ZNF609 HNRNPCL1 RRP1B GAPDH PABPC4 POGZ MEF2D HNRNPCL3 PARP1 BBX UBTF MKI67 PDS5A PUM3 UQCRC1 HSPA2 HNRNPCL2 RANGAP1 REXO4 NSD2 CHAF1A NSD1 MACROH2A1 ZDBF2 PABPC1 GTF2I BRD2 FANCI PABPC3 RPA1 PPIAL4G XRCC6 | 2.02e-06 | 1000 | 272 | 33 | int:SMC5 |
| Interaction | CENPA interactions | RRP1B PARP1 BBX UBTF PDS5A PPIL2 TMCO1 REXO4 NSD2 CHAF1A NSD1 MACROH2A1 E2F6 SRBD1 GTF2I BRD2 RPA1 XRCC6 | 4.07e-06 | 377 | 272 | 18 | int:CENPA |
| Interaction | GSK3A interactions | DENND4A RRP1B PABPC4 KIAA0586 MPDZ SRP54 HELB PARP1 ALMS1 UBTF GLUD1 RASAL2 VCL KIF26B ZDBF2 SRBD1 PABPC1 DENND4C FAM193A RPA1 | 5.52e-06 | 464 | 272 | 20 | int:GSK3A |
| Interaction | RNF123 interactions | GAPDH CSMD2 PCDH17 FANCA SLC38A10 AP3S1 R3HCC1L PNPLA1 P3H1 VPS13A ARID5B PDS5A KAZN ARHGAP20 RANGAP1 REXO4 ANK1 KIF26B COL28A1 UBR4 OR52L1 ZNF316 LRRC40 PRR35 ABCE1 RPA1 XRCC6 SP7 | 7.42e-06 | 824 | 272 | 28 | int:RNF123 |
| Interaction | KCNA3 interactions | AHCYL1 GAPDH RPN2 PABPC4 MPDZ PARP1 AP3S1 UBTF VPS13A PDS5A IQGAP3 RASAL2 VCL RANGAP1 ANK3 COPA TCOF1 LRRC40 PABPC1 DENND4C PREB CCT6A ABCE1 FANCI GEMIN4 RP1 PATJ RPA1 XRCC6 | 7.45e-06 | 871 | 272 | 29 | int:KCNA3 |
| Interaction | EED interactions | NOLC1 ASXL1 PNKP MYO1E RRP1B GAPDH RPN2 POGZ DBT HNF4A MYEF2 JARID2 PTK2B PARP1 STXBP2 TJP2 PDS5A PUM3 TMCO1 HNRNPCL2 FLII RANGAP1 COPA TCOF1 NSD2 UBR4 NSD1 LRRC40 MACROH2A1 E2F6 CHRAC1 PABPC1 LDLR CCT6A GTF2I ABCE1 RPA1 CPSF3 XRCC6 AQR | 1.15e-05 | 1445 | 272 | 40 | int:EED |
| Interaction | PMS1 interactions | 1.26e-05 | 105 | 272 | 9 | int:PMS1 | |
| Interaction | NUP43 interactions | ZNF609 RRP1B GAPDH CCDC168 POGZ HELB BBX UBTF MKI67 TAF2 RANGAP1 REXO4 NSD2 ZNF316 NSD1 MACROH2A1 ZDBF2 E2F6 TDRD7 CCT6A GTF2I FANCI AHNAK2 | 1.45e-05 | 625 | 272 | 23 | int:NUP43 |
| Interaction | SLC4A3 interactions | 1.48e-05 | 12 | 272 | 4 | int:SLC4A3 | |
| Interaction | YWHAH interactions | NOLC1 DENND4A MYO1E STXBP4 CFTR MPDZ MEF2D ENKD1 PTPN3 ALMS1 SBF1 STARD9 TJP2 PPIL2 HERC1 CLEC16A WNK3 RASAL2 VCL TRAPPC11 KIF26B PARD3B RAB11FIP1 RGS12 DENND4C GSS SH3PXD2B ABCE1 SH3PXD2A PATJ RPA1 AQR AHNAK2 | 1.54e-05 | 1102 | 272 | 33 | int:YWHAH |
| Interaction | BAP1 interactions | ASXL1 AHCYL1 HK1 GAPDH PABPC4 ETFA MPDZ HNF4A PHKA1 PARP1 STXBP2 ALDH1L2 GLUD1 PDS5A HSPA2 IQGAP3 GOT1 VCL FLII RANGAP1 ANK3 COPA TCOF1 UBR4 AHCYL2 AIP MORC4 PABPC1 LAP3 GSS CCT6A GTF2I FANCI GEMIN4 PATJ RPA1 XRCC6 | 1.76e-05 | 1314 | 272 | 37 | int:BAP1 |
| Interaction | PRC1 interactions | NOLC1 MYO1E RRP1B GAPDH RPN2 PABPC1L2A PABPC4 MKI67 PDS5A PUM3 HERC1 IQGAP3 HNRNPCL2 VCL ANKRD35 RANGAP1 MACROH2A1 MORC4 PABPC1 RGS12 SPTBN4 CCT6A BRF1 BRD2 PABPC3 GEMIN4 PATJ RPA1 XRCC6 AQR | 2.25e-05 | 973 | 272 | 30 | int:PRC1 |
| Interaction | SUZ12 interactions | NOLC1 MYO1E PABPC4 HNF4A HELB JARID2 PARP1 ALMS1 UBTF MKI67 PDS5A HNRNPCL2 COPA CHAF1A PARD3B MACROH2A1 MORC4 CCDC141 CCT6A GTF2I BRD2 RPA1 AQR | 2.33e-05 | 644 | 272 | 23 | int:SUZ12 |
| Interaction | VDAC2 interactions | ASXL1 HK1 RPN2 CFTR ITGAV NDUFV1 LRRC42 MKI67 UQCRC1 DNAH8 HNRNPCL2 RANGAP1 PREB ABCE1 DNAJC11 ATP1A3 RPA1 XRCC6 | 2.57e-05 | 432 | 272 | 18 | int:VDAC2 |
| Interaction | RHOA interactions | EPHB4 AHCYL1 HK1 MYO1E RPN2 CFTR ETFA DGKQ ITGAV NDUFV1 PCDH17 PARP1 SBF1 GLUD1 VPS13A MKI67 TJP2 ARHGAP20 TMCO1 CLEC16A IQGAP3 RASAL2 ANK3 PARD3B MACROH2A1 RAB11FIP1 SLC4A2 ADGRG6 PREB ABCE1 GEMIN4 PKN1 PATJ RPA1 | 3.45e-05 | 1199 | 272 | 34 | int:RHOA |
| Interaction | GNL1 interactions | 3.47e-05 | 92 | 272 | 8 | int:GNL1 | |
| Interaction | ZNF330 interactions | NOLC1 RRP1B PARP1 BBX UBTF PDS5A PUM3 PPIL2 REXO4 NSD2 CHAF1A NSD1 MACROH2A1 E2F6 SRBD1 BRD2 FANCI XRCC6 | 3.90e-05 | 446 | 272 | 18 | int:ZNF330 |
| Interaction | ETFB interactions | AHCYL1 RPN2 DNAJC19 ETFA ETFDH DBT NDUFV1 GLUD1 NOS1 CLEC16A MTRF1L RANGAP1 RPA1 | 4.26e-05 | 253 | 272 | 13 | int:ETFB |
| Interaction | BRD3 interactions | NOLC1 PNKP RRP1B POGZ PARP1 BBX UBTF MKI67 TAF2 NOVA2 NSD2 CHAF1A NSD1 MACROH2A1 E2F6 RAB11FIP1 TEP1 PLCD3 BRD2 | 4.56e-05 | 494 | 272 | 19 | int:BRD3 |
| Interaction | GDI2 interactions | ASXL1 MYLK CFTR VPS33A PARP1 TJP2 MACROH2A1 AIP PRKCE RPA1 XRCC6 | 4.94e-05 | 187 | 272 | 11 | int:GDI2 |
| Interaction | SMARCA1 interactions | MYO1E POGZ PARP1 CLEC16A HNRNPCL2 CHAF1A MACROH2A1 CHRAC1 BRD2 INAVA RPA1 | 5.19e-05 | 188 | 272 | 11 | int:SMARCA1 |
| Interaction | ELF2 interactions | 5.29e-05 | 156 | 272 | 10 | int:ELF2 | |
| Interaction | SMARCA5 interactions | AHCYL1 MYO1E PARP1 UBTF CLEC16A HNRNPCL2 FLII REXO4 NSD2 CHAF1A MACROH2A1 CHRAC1 MYLK2 BRD2 ABCE1 RPA1 XRCC6 | 5.32e-05 | 415 | 272 | 17 | int:SMARCA5 |
| Interaction | DDX20 interactions | ASXL1 PNKP CFTR SRP54 STXBP2 COPA NSD2 CHAF1A PLCD3 CCT6A GEMIN4 RPA1 | 5.62e-05 | 224 | 272 | 12 | int:DDX20 |
| Interaction | ARAF interactions | RPN2 PABPC4 PARP1 P3H1 GLUD1 CLEC16A COPA TCOF1 E2F6 AIP PABPC1 RGS12 CCT6A FANCI GEMIN4 RPA1 | 5.65e-05 | 376 | 272 | 16 | int:ARAF |
| Interaction | ZC3H3 interactions | AHCYL1 PTTG1 RRP1B PABPC4 PUM3 KIF3C REXO4 NSD2 AHCYL2 WDR74 BRD2 PABPC3 | 6.13e-05 | 226 | 272 | 12 | int:ZC3H3 |
| Interaction | CBX3 interactions | MYO1E POGZ PARP1 BBX UBTF MKI67 PDS5A PPIL2 REXO4 TCOF1 NSD2 CHAF1A ZNF316 NSD1 MACROH2A1 E2F6 LAP3 GTF2I BRD2 ABCE1 RPA1 XRCC6 | 7.10e-05 | 646 | 272 | 22 | int:CBX3 |
| Interaction | ECT2 interactions | NOLC1 AHCYL1 MYO1E RRP1B PABPC1L2A PABPC4 ETFA PARP1 AP3S1 MKI67 TJP2 TAF2 HNRNPCL2 FLII PDZD9 COPA TCOF1 MACROH2A1 PABPC1 SPTBN4 GTF2I BRF1 PABPC3 GEMIN4 HACL1 XRCC6 AHNAK2 | 7.31e-05 | 887 | 272 | 27 | int:ECT2 |
| Interaction | METTL14 interactions | NOLC1 GAPDH RPN2 CHDH CFTR PARP1 SLC38A10 UBTF GLUD1 GLUD2 HERC1 HSPA2 COPA MACROH2A1 CCT6A BRD2 ABCE1 GEMIN4 RPA1 XRCC6 | 7.64e-05 | 558 | 272 | 20 | int:METTL14 |
| Interaction | PPM1M interactions | 7.71e-05 | 53 | 272 | 6 | int:PPM1M | |
| Interaction | PHIP interactions | NOLC1 ZNF609 DBT MYEF2 PARP1 TAF2 HNRNPCL2 VCL BRD2 ZFHX4 RPA1 | 7.91e-05 | 197 | 272 | 11 | int:PHIP |
| Interaction | ENO1 interactions | ASXL1 ZNF609 MYO1E GAPDH CFTR MPDZ POGZ FANCA LRRC42 VPS13A DNAH8 PMP2 RANGAP1 ANK3 NSD2 AIP MORC4 TDRD7 UPF2 RNF38 RPA1 XRCC6 MVK | 8.50e-05 | 701 | 272 | 23 | int:ENO1 |
| Interaction | H3-3A interactions | RRP1B POGZ HNF4A PARP1 BBX UBTF MKI67 PDS5A PUM3 PPIL2 TAF2 REXO4 NSD2 CHAF1A NSD1 MACROH2A1 SRBD1 MYLK2 GTF2I BRD2 FANCI DNAJC11 RPA1 XRCC6 | 8.57e-05 | 749 | 272 | 24 | int:H3-3A |
| Interaction | DNAJC17 interactions | 8.74e-05 | 134 | 272 | 9 | int:DNAJC17 | |
| Interaction | OGT interactions | NOLC1 ASXL1 PNKP RRP1B GAPDH PABPC4 SRP54 DBT NDUFV1 MYEF2 PARP1 P3H1 GLUD1 MKI67 PDS5A UQCRC1 CLEC16A RANGAP1 REXO4 NSD2 ZNF385A PABPC1 LAP3 GSS CCT6A RPA1 HSPA14 XRCC6 | 9.29e-05 | 950 | 272 | 28 | int:OGT |
| Interaction | H3C1 interactions | RRP1B GAPDH POGZ PARP1 BBX UBTF MKI67 PDS5A PPIL2 TAF2 DNAH8 REXO4 ANK3 NSD2 CHAF1A UBR4 LAMA2 NSD1 MACROH2A1 SRBD1 MYLK2 BRD2 PABPC3 UGGT2 RPA1 XRCC6 AQR | 9.48e-05 | 901 | 272 | 27 | int:H3C1 |
| Interaction | RHOG interactions | EPHB4 AHCYL1 MYO1E DNAJC19 ETFA DBT ITGAV NDUFV1 PCDH17 CCR2 PNPT1 SBF1 ALDH1L2 GLUD1 VPS13A RASAL2 AMIGO2 ANK3 KIF26B MACROH2A1 RAB11FIP1 SLC4A2 ADGRG6 PREB ABCE1 RPA1 AHNAK2 | 1.12e-04 | 910 | 272 | 27 | int:RHOG |
| Interaction | ARHGAP24 interactions | AHCYL1 RRP1B GAPDH RPN2 PARP1 P3H1 WNK3 GOT1 VCL AHCYL2 PABPC1 CCT6A GTF2I ABCE1 PABPC3 DNAJC11 RPA1 XRCC6 | 1.16e-04 | 486 | 272 | 18 | int:ARHGAP24 |
| Interaction | HMGA2 interactions | 1.22e-04 | 140 | 272 | 9 | int:HMGA2 | |
| Interaction | SHMT2 interactions | HK1 MYLK MYO1E DNAJC19 MPDZ DGKQ MEF2D PARP1 LRRC42 GLUD2 PUM3 CLEC16A MTRF1L GOT1 COPA UBR4 MORC4 PRKCE ATP1A3 RPA1 XRCC6 AQR | 1.23e-04 | 671 | 272 | 22 | int:SHMT2 |
| Interaction | POLR1G interactions | NOLC1 RRP1B POGZ BBX UBTF PDS5A PUM3 PPIL2 TAF2 REXO4 TCOF1 NSD2 CHAF1A UBR4 NSD1 E2F6 BRD2 XRCC6 | 1.26e-04 | 489 | 272 | 18 | int:POLR1G |
| Interaction | FOXQ1 interactions | 1.29e-04 | 141 | 272 | 9 | int:FOXQ1 | |
| Interaction | GSK3B interactions | DENND4A HK1 RRP1B GAPDH KIAA0586 MPDZ SRP54 HELB PARP1 ALMS1 MKI67 HSPA2 RASAL2 VCL KIF26B ZDBF2 PABPC1 DENND4C SPTBN4 CCT6A FAM193A ABCE1 ENTPD6 GEMIN4 RPA1 SP7 | 1.29e-04 | 868 | 272 | 26 | int:GSK3B |
| Interaction | PCF11 interactions | 1.32e-04 | 111 | 272 | 8 | int:PCF11 | |
| Interaction | RCOR1 interactions | AHCYL1 VPS33A ALMS1 ARID5B MKI67 FLII UBR4 MACROH2A1 ZDBF2 E2F6 MORC4 DENND4C GTF2I FAM193A ZFHX4 ZNF827 GEMIN4 SP7 | 1.42e-04 | 494 | 272 | 18 | int:RCOR1 |
| Interaction | PPM1G interactions | AHCYL1 RPN2 DNAJC19 PARP1 CLEC16A WNK3 COPA TCOF1 CHAF1A OAS3 ABCE1 PKN1 RPA1 XRCC6 | 1.44e-04 | 325 | 272 | 14 | int:PPM1G |
| Interaction | H3C3 interactions | RRP1B POGZ PARP1 BBX UBTF MKI67 PDS5A PUM3 REXO4 NSD2 CHAF1A NSD1 SRBD1 GTF2I BRD2 FANCI RPA1 XRCC6 | 1.46e-04 | 495 | 272 | 18 | int:H3C3 |
| Interaction | STARD9 interactions | 1.51e-04 | 38 | 272 | 5 | int:STARD9 | |
| Interaction | XRCC4 interactions | 1.59e-04 | 114 | 272 | 8 | int:XRCC4 | |
| Interaction | SNRNP40 interactions | ZNF609 MYO1E RRP1B GAPDH POGZ UBTF MKI67 PPIL2 REXO4 TCOF1 NSD2 ZNF316 MACROH2A1 ZDBF2 AIP SRBD1 CCT6A FANCI TNKS2 RPA1 AQR | 1.63e-04 | 637 | 272 | 21 | int:SNRNP40 |
| Interaction | YWHAG interactions | NOLC1 DENND4A GAPDH STXBP4 CFTR PABPC4 MPDZ MEF2D ENKD1 PTPN3 ALMS1 SBF1 STARD9 TJP2 RASAL2 VCL TRAPPC11 KIF26B CHAF1A PARD3B RAB11FIP1 PABPC1 RGS12 DENND4C MYLK2 GSS SH3PXD2A PRKCE PATJ RPA1 CPSF3 AQR AHNAK2 | 1.71e-04 | 1248 | 272 | 33 | int:YWHAG |
| Interaction | H2BC5 interactions | NOLC1 HNRNPCL1 MYO1E GAPDH JARID2 PARP1 MKI67 TRPM8 HERC1 REXO4 TCOF1 PCDHGB1 PCDHGA7 PCDHGA8 | 1.75e-04 | 331 | 272 | 14 | int:H2BC5 |
| Interaction | TOP3B interactions | EPHB4 MYO1E ETFA DGKQ ATG2A ABCA7 FANCA SLC38A10 SBF1 HERC1 IQGAP3 BAHCC1 PLXNA3 FLII NSD2 UBR4 ZNF316 NSD1 MACROH2A1 STK32C TEP1 PABPC1 LDLR PLCD3 SH3PXD2B GTF2I BRD2 CELSR2 UPF2 ZNF827 FANCI ZNF335 PKN1 RPA1 XRCC6 AHNAK2 PPP1R16A | 1.81e-04 | 1470 | 272 | 37 | int:TOP3B |
| Interaction | RBPJ interactions | PNKP HNF4A MEF2D FANCA MAML3 FLII RANGAP1 CHAF1A MACROH2A1 BRD2 RPA1 XRCC6 | 1.85e-04 | 254 | 272 | 12 | int:RBPJ |
| Interaction | WDR5 interactions | ASXL1 MYLK MYO1E GAPDH RPN2 PABPC4 ETFA HNF4A NDUFV1 HELB PARP1 SBF1 TJP2 UTY FLII COPA CHAF1A UBR4 MACROH2A1 E2F6 PABPC1 CCT6A GTF2I ABCE1 ZNF335 DNAJC11 PKN1 RPA1 XRCC6 ACSL5 | 2.06e-04 | 1101 | 272 | 30 | int:WDR5 |
| Interaction | PARP1 interactions | NOLC1 PNKP MYO1E RRP1B GAPDH CFTR POGZ PARP1 BBX STARD9 UBTF GLUD1 MKI67 PDS5A HSPA2 IQGAP3 FLII RANGAP1 REXO4 NSD2 NSD1 MACROH2A1 ACAD10 CHRAC1 SRBD1 LDLR PREB CCT6A BRF1 BRD2 FANCI RPA1 XRCC6 AQR | 2.09e-04 | 1316 | 272 | 34 | int:PARP1 |
| Interaction | WIZ interactions | POGZ HNF4A PARP1 HSPA2 CHAF1A MACROH2A1 RGS12 BRD2 RPA1 XRCC6 SP7 | 2.09e-04 | 220 | 272 | 11 | int:WIZ |
| Interaction | LMBR1L interactions | EPHB4 CLGN RPN2 CFTR NDUFV1 FANCA P3H1 PDS5A PPIL2 TMCO1 HSPA2 IQGAP3 WNK3 RANGAP1 COPA TCOF1 UBR4 LRRC40 SLC4A2 PREB FANCI PCSK6 DNAJC11 GEMIN4 UGGT2 ATP1A3 HSPA14 | 2.09e-04 | 946 | 272 | 27 | int:LMBR1L |
| Interaction | NNT interactions | 2.17e-04 | 185 | 272 | 10 | int:NNT | |
| Interaction | FLII interactions | ASXL1 AHCYL1 DENND4A RPN2 CFTR VPS33A PARP1 HERC1 NPHP1 FLII BRF1 RNF38 RPA1 | 2.20e-04 | 298 | 272 | 13 | int:FLII |
| Interaction | ACE2 interactions | RRP1B GAPDH RPN2 PABPC4 ETFA SRP54 ENKD1 PARP1 PTPN3 UBTF MKI67 PPIL2 ALDH1A1 CACNA1C COPA TCOF1 CHAF1A UBR4 GPRIN3 MACROH2A1 RAB11FIP1 PABPC1 LDLR WDR74 CCT6A GTF2I BRD2 RPA1 XRCC6 AHNAK2 | 2.23e-04 | 1106 | 272 | 30 | int:ACE2 |
| Interaction | CDC42 interactions | EPHB4 AHCYL1 MYLK MYO1E RPN2 CFTR PABPC4 ETFA ITGAV NDUFV1 PCDH17 BBX SBF1 P3H1 GLUD2 VPS13A MKI67 ARHGAP20 TMCO1 WIPF2 IQGAP3 RASAL2 AMIGO2 ANK3 COPA KIF26B MACROH2A1 AHCYL2 RAB11FIP1 SLC4A2 PREB ABCE1 SH3PXD2A RPA1 | 2.31e-04 | 1323 | 272 | 34 | int:CDC42 |
| Interaction | PLCD3 interactions | 2.40e-04 | 121 | 272 | 8 | int:PLCD3 | |
| Interaction | PARP4 interactions | 2.44e-04 | 42 | 272 | 5 | int:PARP4 | |
| Interaction | MEX3A interactions | ASXL1 PABPC4 PARP1 SBF1 SLC29A4 ANK1 COPA NSD2 LAMA2 NSD1 PABPC1 LDLR SH3PXD2B EYS AHNAK2 | 2.44e-04 | 384 | 272 | 15 | int:MEX3A |
| Interaction | VDAC3 interactions | EPHB4 HNRNPCL1 HK1 RPN2 ITGAV NDUFV1 HNRNPCL3 UQCRC1 DNAH8 CLEC16A HNRNPCL2 ABCE1 RPA1 XRCC6 | 2.52e-04 | 343 | 272 | 14 | int:VDAC3 |
| Interaction | PRKACA interactions | NOLC1 HNRNPCL1 HK1 GAPDH CFTR PABPC4 HNF4A MEF2D PHKA1 R3HCC1L SBF1 NOS1 RASAL2 CACNA1C PABPC1 CCT6A ABCE1 RPA1 | 2.60e-04 | 519 | 272 | 18 | int:PRKACA |
| Interaction | HNF1B interactions | 2.69e-04 | 190 | 272 | 10 | int:HNF1B | |
| Interaction | SPTA1 interactions | 2.84e-04 | 94 | 272 | 7 | int:SPTA1 | |
| Interaction | MECP2 interactions | NOLC1 HNRNPCL1 HK1 RRP1B RPN2 SRP54 POGZ DBT NDUFV1 MYEF2 PNPT1 PARP1 BBX SBF1 MKI67 PDS5A PPIL2 RANGAP1 REXO4 COPA TCOF1 NSD2 NSD1 MACROH2A1 CHRAC1 SRBD1 CCT6A AGO1 BRD2 UPF2 CPSF3 XRCC6 AQR | 2.99e-04 | 1287 | 272 | 33 | int:MECP2 |
| Interaction | ACADVL interactions | 3.18e-04 | 159 | 272 | 9 | int:ACADVL | |
| Interaction | DCPS interactions | PNKP RRP1B GAPDH POGZ PARP1 UBTF MKI67 PUM3 VCL FLII COPA MACROH2A1 GSS WDR74 RPA1 | 3.21e-04 | 394 | 272 | 15 | int:DCPS |
| Interaction | ATP1A1 interactions | ASXL1 AHCYL1 RRP1B RPN2 CFTR NDUFV1 UQCRC1 ALDH1A1 TMCO1 COPA TCOF1 MACROH2A1 STK32C PABPC1 CCT6A ZFHX4 ATP1A3 RPA1 XRCC6 | 3.24e-04 | 575 | 272 | 19 | int:ATP1A1 |
| Interaction | H2BC8 interactions | POGZ PARP1 BBX UBTF ARID5B MKI67 PDS5A PPIL2 REXO4 NSD2 CHAF1A NSD1 MACROH2A1 E2F6 SRBD1 GTF2I BRD2 FANCI XRCC6 | 3.31e-04 | 576 | 272 | 19 | int:H2BC8 |
| Interaction | MEN1 interactions | NOLC1 ZNF609 RRP1B CFTR PABPC4 POGZ MEF2D MYEF2 FANCA UBTF MKI67 TJP2 PDS5A PUM3 KAZN RANGAP1 REXO4 TCOF1 UBR4 SRBD1 PABPC1 GTF2I UPF2 FANCI GEMIN4 RPA1 CPSF3 AQR | 3.46e-04 | 1029 | 272 | 28 | int:MEN1 |
| Interaction | RAC2 interactions | EPHB4 AHCYL1 HNRNPCL1 HK1 MYO1E RPN2 CFTR ITGAV NDUFV1 PCDH17 SBF1 GLUD2 VPS13A UQCRC1 RASAL2 AMIGO2 KIF26B RAB11FIP1 ADGRG6 PREB ABCE1 | 3.47e-04 | 674 | 272 | 21 | int:RAC2 |
| Interaction | NCAPD2 interactions | ASXL1 PTTG1 CFTR PABPC4 PNPT1 PARP1 SBF1 CLEC16A FLII RPA1 XRCC6 | 3.55e-04 | 234 | 272 | 11 | int:NCAPD2 |
| Interaction | GEMIN4 interactions | ASXL1 PNKP GPR84 SRP54 PHKA1 STXBP2 TAF2 NSD2 MORC4 AGO1 GEMIN4 RPA1 | 3.69e-04 | 274 | 272 | 12 | int:GEMIN4 |
| Interaction | NPHP1 interactions | 3.90e-04 | 130 | 272 | 8 | int:NPHP1 | |
| Interaction | SPOP interactions | ACADSB GAPDH PABPC4 ETFA SLC38A10 FLII TCOF1 CHAF1A OAS3 MACROH2A1 PABPC1 LDLR LAP3 BRD2 RPA1 HSPA14 ACSL5 | 3.93e-04 | 491 | 272 | 17 | int:SPOP |
| Interaction | RO60 interactions | AHCYL1 GAPDH PABPC4 CLEC16A FLII MACROH2A1 TEP1 PABPC1 AGO1 RPA1 | 4.04e-04 | 200 | 272 | 10 | int:RO60 |
| Interaction | MAP1B interactions | AHCYL1 HK1 MYO1E GAPDH CFTR GLUD1 GLUD2 MKI67 COPA TCOF1 NSD2 UBR4 MACROH2A1 CCT6A ABCE1 ATP1A3 RPA1 XRCC6 | 4.09e-04 | 539 | 272 | 18 | int:MAP1B |
| Interaction | ARMC5 interactions | PABPC4 ENKD1 PARP1 GLUD1 HSPA2 IQGAP3 VCL PABPC1 PRR35 XRCC6 | 4.20e-04 | 201 | 272 | 10 | int:ARMC5 |
| Interaction | RPL28 interactions | PTTG1 RRP1B CFTR BBX PUM3 TAF2 REXO4 TCOF1 NSD2 ZDBF2 SRBD1 PABPC1 WDR74 GTF2I CELSR2 INAVA RPA1 | 4.21e-04 | 494 | 272 | 17 | int:RPL28 |
| Interaction | YAP1 interactions | CPNE2 AHCYL1 HNRNPCL1 RRP1B GAPDH RPN2 MPDZ POGZ PARP1 TJP2 TAF2 HSPA2 VCL RANGAP1 ANK3 COPA TCOF1 NSD1 MACROH2A1 CHRAC1 PABPC1 CCT6A GTF2I BRD2 PABPC3 RNF38 PATJ RPA1 XRCC6 | 4.21e-04 | 1095 | 272 | 29 | int:YAP1 |
| Interaction | PTPN13 interactions | STXBP4 PARP1 PTPN3 HSPA2 HNRNPCL2 NSD2 DENND4C SH3PXD2A RPA1 EPHA4 | 4.37e-04 | 202 | 272 | 10 | int:PTPN13 |
| Interaction | TOMM20 interactions | HK1 CFTR PABPC4 ETFA VPS13A MACROH2A1 AIP ABCE1 DNAJC11 PRKCE RPA1 | 4.40e-04 | 240 | 272 | 11 | int:TOMM20 |
| Interaction | GLDC interactions | RRP1B PABPC4 MPDZ PARP1 TJP2 FLII RANGAP1 PABPC1 GTF2I AGO1 PATJ RPA1 CPSF3 | 4.48e-04 | 321 | 272 | 13 | int:GLDC |
| Interaction | BAZ2A interactions | 4.57e-04 | 73 | 272 | 6 | int:BAZ2A | |
| Interaction | PPP1R12A interactions | AHCYL1 MYLK GAPDH RPN2 CFTR P3H1 HSPA2 FLII CHAF1A PLCD3 BRF1 RNF38 RPA1 | 4.61e-04 | 322 | 272 | 13 | int:PPP1R12A |
| GeneFamily | PDZ domain containing | STXBP4 MPDZ PTPN3 TJP2 NOS1 PDZD9 PARD3B RGS12 PRX PATJ AHNAK2 | 3.40e-07 | 152 | 179 | 11 | 1220 |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 9.99e-05 | 25 | 179 | 4 | 504 | |
| Coexpression | GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN | PTTG1 IRF4 FANCA ARID5B LAMA2 OAS3 RAB11FIP1 LAP3 ADGRG6 ARG2 IL7 | 8.94e-06 | 199 | 275 | 11 | M3093 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | NOLC1 CLGN GAPDH SRP54 NDUFV1 GLUD1 ARID5B MKI67 TJP2 UQCRC1 ALDH1A1 GOT1 VCL RANGAP1 CHAF1A LDLR GSS FANCI ENTPD6 RPA1 XRCC6 | 9.13e-06 | 669 | 275 | 21 | M18635 |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP | PABPC4 NDUFV1 GLUD1 GLUD2 UQCRC1 COPA PABPC1 LAP3 RNF38 PKN1 XRCC6 | 9.37e-06 | 200 | 275 | 11 | M5779 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 PTTG1 RRP1B KIAA0586 MTSS1 ENKD1 FANCA HROB MKI67 IQGAP3 RANGAP1 TCOF1 NSD2 PABPC1 LDLR ADGRG6 FANCI PABPC3 RPA1 | 2.03e-05 | 597 | 275 | 19 | MM1309 |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 2.64e-05 | 147 | 275 | 9 | M2387 | |
| Coexpression | GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN | 3.37e-05 | 117 | 275 | 8 | M42507 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | PTTG1 GAPDH MYEF2 FANCA ALMS1 ALDH1L2 MKI67 ARHGAP20 IQGAP3 NPHP1 PLXNA3 RANGAP1 NSD2 CHAF1A LRRC40 MACROH2A1 CELSR2 FANCI RPA1 XRCC6 | 3.76e-05 | 680 | 275 | 20 | MM456 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 PTTG1 RRP1B KIAA0586 MTSS1 ENKD1 FANCA HROB MKI67 IQGAP3 RANGAP1 TCOF1 NSD2 PABPC1 LDLR ADGRG6 FANCI RPA1 | 4.46e-05 | 578 | 275 | 18 | M2368 |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 4.65e-05 | 158 | 275 | 9 | MM934 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP | PTTG1 MYLK ACADSB FANCA PNPT1 NOS1 SLC29A4 MACROH2A1 PRX LPO | 5.15e-05 | 199 | 275 | 10 | M3886 |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | ASXL1 AHCYL1 POGZ ARHGAP20 DNAH8 FOXN2 AHCYL2 ZNF385A ADGRG6 PLCD3 | 5.37e-05 | 200 | 275 | 10 | M7776 |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 5.69e-05 | 93 | 275 | 7 | M4752 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | EFCAB5 ZNF609 NCKAP5 CCDC168 CSMD2 JARID2 HFM1 UBR4 HEATR5A EYS AGO1 EEPD1 RNF39 | 2.95e-12 | 135 | 276 | 13 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MDGA2 C6orf118 NALF1 KAZN MAML3 SLC27A6 KIF26B PARD3B ADGRG6 EVA1C | 2.53e-07 | 185 | 276 | 10 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MDGA2 C6orf118 NALF1 KAZN MAML3 SLC27A6 KIF26B PARD3B ADGRG6 EVA1C | 2.53e-07 | 185 | 276 | 10 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | HNF4A JARID2 GLUD1 MAML3 NPNT DENND5B KIF26B NSD2 PARD3B SH3PXD2A | 2.65e-07 | 186 | 276 | 10 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | HNF4A JARID2 GLUD1 MAML3 NPNT DENND5B KIF26B NSD2 PARD3B SH3PXD2A | 2.65e-07 | 186 | 276 | 10 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.98e-07 | 149 | 276 | 9 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.51e-07 | 197 | 276 | 10 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | MTSS1 NCKAP5 MAML3 AMIGO2 OVOS2 RGS12 EEPD1 PCSK6 SORCS3 SP7 | 5.18e-07 | 200 | 276 | 10 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | MTSS1 NCKAP5 MAML3 AMIGO2 OVOS2 RGS12 EEPD1 PCSK6 SORCS3 SP7 | 5.18e-07 | 200 | 276 | 10 | c74bc12e13d002dedaaf75a2244ec111e47524e1 |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 6.53e-07 | 158 | 276 | 9 | f433bc189f000efa34e8e09ab32b3fa22bcf64c4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 167 | 276 | 9 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.09e-06 | 168 | 276 | 9 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-06 | 179 | 276 | 9 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 1.93e-06 | 180 | 276 | 9 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 180 | 276 | 9 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.02e-06 | 181 | 276 | 9 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.02e-06 | 181 | 276 | 9 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.02e-06 | 181 | 276 | 9 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | MDGA2 CSMD2 ALDH1A1 PMP2 COL28A1 ZFHX4 PCSK6 KIAA1755 EGFLAM | 2.12e-06 | 182 | 276 | 9 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-06 | 184 | 276 | 9 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.32e-06 | 184 | 276 | 9 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-06 | 184 | 276 | 9 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.64e-06 | 187 | 276 | 9 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.76e-06 | 188 | 276 | 9 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-06 | 188 | 276 | 9 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.76e-06 | 188 | 276 | 9 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 2.76e-06 | 188 | 276 | 9 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-06 | 190 | 276 | 9 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 3.01e-06 | 190 | 276 | 9 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 3.15e-06 | 191 | 276 | 9 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 192 | 276 | 9 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 192 | 276 | 9 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.28e-06 | 192 | 276 | 9 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 3.28e-06 | 192 | 276 | 9 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 192 | 276 | 9 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 192 | 276 | 9 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 3.28e-06 | 192 | 276 | 9 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.42e-06 | 193 | 276 | 9 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 3.42e-06 | 193 | 276 | 9 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.42e-06 | 193 | 276 | 9 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.42e-06 | 193 | 276 | 9 | 8f57b0473a2c2c07f83e5fe70f16862b1bb3b514 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.42e-06 | 193 | 276 | 9 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.42e-06 | 193 | 276 | 9 | 3ba6d44248690b80f4caf791d463e60f1ab816c4 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 3.42e-06 | 193 | 276 | 9 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-06 | 194 | 276 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.73e-06 | 195 | 276 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 3.88e-06 | 196 | 276 | 9 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.05e-06 | 197 | 276 | 9 | cd7e34318b4ae72b7b312fda8cc0e041c2ac4ab5 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.05e-06 | 197 | 276 | 9 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.05e-06 | 197 | 276 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.05e-06 | 197 | 276 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.22e-06 | 198 | 276 | 9 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-06 | 198 | 276 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.38e-06 | 69 | 276 | 6 | 24a480394630385ee51b1dfe1123480107a11403 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.38e-06 | 69 | 276 | 6 | 1ab1d92e03a31bb1fe87f055d407a81c4d1d81b8 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 4.39e-06 | 199 | 276 | 9 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 4.39e-06 | 199 | 276 | 9 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.39e-06 | 199 | 276 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.58e-06 | 200 | 276 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.58e-06 | 200 | 276 | 9 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | PBMC-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 4.96e-06 | 152 | 276 | 8 | 1a3f8ed476aa9a39742b4684be2c704669e4a3d0 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.00e-06 | 156 | 276 | 8 | 6c8f442ed94ae31e6832b68137e98ae78091ac6c | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 163 | 276 | 8 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 163 | 276 | 8 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-06 | 166 | 276 | 8 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.03e-05 | 168 | 276 | 8 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.05e-05 | 121 | 276 | 7 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.13e-05 | 170 | 276 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 171 | 276 | 8 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 172 | 276 | 8 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | (05)_Ciliated-(2)_48hpi|(05)_Ciliated / shred by cell type and Timepoint | 1.24e-05 | 124 | 276 | 7 | fc8cce8c1809edafbc4e69e501dd4f016f5dfc0b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-05 | 173 | 276 | 8 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 175 | 276 | 8 | 3bca1aac2a2a1f46753b5f9462888f144ed8327b | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 176 | 276 | 8 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 176 | 276 | 8 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 177 | 276 | 8 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 177 | 276 | 8 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 177 | 276 | 8 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 177 | 276 | 8 | 9b02fd91c110b405eba6cb74ceb90b1286535973 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 178 | 276 | 8 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-05 | 180 | 276 | 8 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 181 | 276 | 8 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 181 | 276 | 8 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 181 | 276 | 8 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.84e-05 | 182 | 276 | 8 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-05 | 182 | 276 | 8 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-05 | 182 | 276 | 8 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.92e-05 | 183 | 276 | 8 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-05 | 183 | 276 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 183 | 276 | 8 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-05 | 183 | 276 | 8 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 185 | 276 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.07e-05 | 185 | 276 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 185 | 276 | 8 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 2.07e-05 | 185 | 276 | 8 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 185 | 276 | 8 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | normal-na-Myeloid-conventional_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.07e-05 | 185 | 276 | 8 | 67e881a89a491665b8c612fff084c202c0c79235 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 185 | 276 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.16e-05 | 186 | 276 | 8 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 186 | 276 | 8 | e83718fabb057100835d3357df407f283d23fe16 | |
| Computational | Response to DNA damage. | 7.62e-05 | 187 | 154 | 11 | MODULE_244 | |
| Drug | isovaleryl-CoA | 3.18e-06 | 53 | 273 | 7 | CID000000810 | |
| Drug | AC1L1GTQ | 3.61e-06 | 54 | 273 | 7 | CID000003836 | |
| Drug | iodine monochloride | 4.15e-06 | 21 | 273 | 5 | CID000024640 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | ZNF609 MYO1E RRP1B NKX3-2 BTN2A2 HROB PPIL2 KAZN PLA2G3 LDLR PATJ MVK | 4.21e-06 | 194 | 273 | 12 | 1024_UP |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A | RRP1B KIAA0586 MPDZ SLC38A10 VPS13A MKI67 CLEC16A RANGAP1 REXO4 CHAF1A ARG2 GEMIN4 | 4.21e-06 | 194 | 273 | 12 | 1822_DN |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | ZNF609 ABCA7 PCDH17 KIF3C RASAL2 BAHCC1 RANGAP1 ANK1 ANK3 UBR4 SH3PXD2A PRKCE | 5.76e-06 | 200 | 273 | 12 | 2912_UP |
| Drug | pentenoic acid | 6.76e-06 | 4 | 273 | 3 | CID000012299 | |
| Drug | nitroparacetamol | 9.28e-06 | 12 | 273 | 4 | CID006918532 | |
| Drug | AlaGlu | 1.33e-05 | 13 | 273 | 4 | CID000128841 | |
| Drug | adenine N1-oxide | 1.68e-05 | 5 | 273 | 3 | CID000093557 | |
| Drug | choline sulfate | 1.68e-05 | 5 | 273 | 3 | CID000000485 | |
| Drug | AC1Q68Z5 | HK1 ACADSB GAPDH ETFA DBT FANCA UBTF GLUD1 GLUD2 VPS13A MAML3 SLC29A4 GOT1 ACAD10 HACL1 MVK | 1.91e-05 | 386 | 273 | 16 | CID000000181 |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | CLGN MTSS1 NALF1 SBF1 TRPM8 NPHP1 DENND5B PLA2G3 LDLR ATP1A3 AHNAK2 | 2.17e-05 | 192 | 273 | 11 | 3236_UP |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | ZNF609 KIAA0586 PPIL2 PLXNA3 FOXN2 PLA2G3 OAS3 ACAD10 AHCYL2 LDLR MVK | 2.39e-05 | 194 | 273 | 11 | 1480_DN |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | NKX3-2 MPDZ KAZN WIPF2 NSD2 CHAF1A AHCYL2 ARG2 WDR74 MCM9 EPHA4 | 2.63e-05 | 196 | 273 | 11 | 7265_DN |
| Drug | AC1L9HHR | MYLK MYO1E CFTR DGKQ ABCA7 PARP1 VCL PMP2 ANK1 MACROH2A1 MYLK2 SPTBN4 PRKCE PKN1 TNKS2 | 2.70e-05 | 354 | 273 | 15 | CID000445141 |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | MYO1E ACADSB KIAA0586 BTN2A2 C11orf68 PPIL2 CHAF1A BRF1 PCSK6 UGGT2 MVK | 2.76e-05 | 197 | 273 | 11 | 7431_DN |
| Drug | pentamidine isethionate salt; Down 200; 100uM; MCF7; HG-U133A | DBT ARID5B PDS5A PPIL2 ANK3 TCOF1 LDLR ZNF335 GEMIN4 AQR EPHA4 | 2.76e-05 | 197 | 273 | 11 | 639_DN |
| Drug | ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | MPDZ UBTF MKI67 PDS5A HSPA2 AMIGO2 RANGAP1 SLC27A6 NSD2 GTF2I RNF38 | 2.76e-05 | 197 | 273 | 11 | 882_DN |
| Drug | flavin adenine dinucleotide sodium | ACADSB CHDH ETFA ETFDH DBT NDUFV1 GLUD1 GLUD2 UQCRC1 NOS1 DMGDH ACAD10 GTF2I BRD2 ATP1A3 | 2.88e-05 | 356 | 273 | 15 | CID000000703 |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; HL60; HT_HG-U133A | MYO1E IRF4 HNF4A FANCA TRPM8 HSPA2 NPHP1 COPA PLA2G3 ST6GAL1 PCSK6 | 3.03e-05 | 199 | 273 | 11 | 2730_UP |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; HL60; HT_HG-U133A | RRP1B VPS33A DBT CHRNG PTK2B RASAL2 NOVA2 ANK3 UBR4 LAMA2 RGS12 | 3.17e-05 | 200 | 273 | 11 | 2575_UP |
| Drug | AC1Q68ZE | 4.58e-05 | 79 | 273 | 7 | CID000000265 | |
| Drug | 2-hydroxyglutarate | 5.00e-05 | 34 | 273 | 5 | CID000000043 | |
| Drug | 2-oxoglutaconic acid | 5.76e-05 | 7 | 273 | 3 | CID006443759 | |
| Drug | aureothricin | 5.76e-05 | 7 | 273 | 3 | CID000068460 | |
| Drug | tricetin | 6.64e-05 | 36 | 273 | 5 | CID005281701 | |
| Drug | adipic acid | 6.75e-05 | 58 | 273 | 6 | CID000000196 | |
| Drug | SM-2 | 8.51e-05 | 87 | 273 | 7 | CID000486033 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | ZNF609 NKX3-2 BTN2A2 PPIL2 BAHCC1 DENND5B RNF44 OAS3 LDLR PATJ | 8.75e-05 | 186 | 273 | 10 | 6996_UP |
| Drug | 2'(3')-O-(2,4,6-trinitrophenyl)-ADP | 9.13e-05 | 8 | 273 | 3 | CID000644359 | |
| Drug | Ag43 | 9.13e-05 | 8 | 273 | 3 | CID000005613 | |
| Drug | trimethyllead chloride | 9.13e-05 | 8 | 273 | 3 | CID000223969 | |
| Drug | Nessler's reagent | 9.13e-05 | 8 | 273 | 3 | CID000024542 | |
| Drug | 2-methylbutyrylglycine | 9.13e-05 | 8 | 273 | 3 | CID000193872 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 9.15e-05 | 187 | 273 | 10 | 6978_UP | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 191 | 273 | 10 | 4811_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A | VPS33A PTK2B VPS13A PPIL2 KAZN UTY COPA CELSR2 SH3PXD2A ENTPD6 | 1.09e-04 | 191 | 273 | 10 | 3123_DN |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.14e-04 | 192 | 273 | 10 | 1517_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 192 | 273 | 10 | 2865_DN | |
| Drug | phenanthridinone; Down 200; 51.2uM; MCF7; HT_HG-U133A_EA | ZNF609 DBT ALMS1 ARID5B MKI67 SLC27A6 TCOF1 CHAF1A GTF2I EPHA4 | 1.24e-04 | 194 | 273 | 10 | 1115_DN |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 1.24e-04 | 194 | 273 | 10 | 4838_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 1.29e-04 | 195 | 273 | 10 | 4502_DN | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 1.29e-04 | 195 | 273 | 10 | 681_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.35e-04 | 196 | 273 | 10 | 7123_UP | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; HL60; HG-U133A | 1.35e-04 | 196 | 273 | 10 | 1606_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | EPHB4 R3HCC1L PPIL2 NOS1 UTY RASAL2 BAHCC1 AHCYL2 RGS12 GTF2I | 1.35e-04 | 196 | 273 | 10 | 4120_DN |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | MPDZ PTK2B R3HCC1L PPIL2 MLPH BAHCC1 ANK3 IBSP AHCYL2 CELSR2 | 1.35e-04 | 196 | 273 | 10 | 2697_DN |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.35e-04 | 196 | 273 | 10 | 2080_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 273 | 10 | 6776_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A | DGKQ MEF2D HROB DENND5B ANK1 SHH ST6GAL1 SH3PXD2A PCSK6 PRKCE | 1.41e-04 | 197 | 273 | 10 | 2751_UP |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.41e-04 | 197 | 273 | 10 | 6325_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | KIAA0586 VPS33A ALMS1 TMCO1 COPA SLC27A6 CHAF1A SRBD1 WDR74 MVK | 1.41e-04 | 197 | 273 | 10 | 5311_DN |
| Drug | phenyltriethoxysilane | 1.43e-04 | 2 | 273 | 2 | CID000013075 | |
| Drug | G-3SH | 1.43e-04 | 2 | 273 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 1.43e-04 | 2 | 273 | 2 | CID006455327 | |
| Drug | methylmercuric bromide | 1.43e-04 | 2 | 273 | 2 | CID000068175 | |
| Drug | AC1LD6BO | 1.43e-04 | 2 | 273 | 2 | CID000612818 | |
| Drug | 5-methylisophthalate | 1.43e-04 | 2 | 273 | 2 | CID000068137 | |
| Drug | 5-undecyloxolan-2-one | 1.43e-04 | 2 | 273 | 2 | CID000007785 | |
| Drug | x 1 s | 1.43e-04 | 2 | 273 | 2 | CID000409694 | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A | GDF5 MEF2D NALF1 ALMS1 NPHP1 UBR4 TEP1 SH3PXD2A PCSK6 AHNAK2 | 1.46e-04 | 198 | 273 | 10 | 2878_UP |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.46e-04 | 198 | 273 | 10 | 7327_UP | |
| Drug | Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A | 1.46e-04 | 198 | 273 | 10 | 6560_UP | |
| Drug | arachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A | 1.46e-04 | 198 | 273 | 10 | 594_DN | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; HL60; HT_HG-U133A | 1.46e-04 | 198 | 273 | 10 | 2175_UP | |
| Drug | NSC303808 | 1.50e-04 | 23 | 273 | 4 | CID000327720 | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; HL60; HT_HG-U133A | RRP1B PTK2B BTN2A2 HROB R3HCC1L AMIGO2 ANK3 PRX CELSR2 PCSK6 | 1.53e-04 | 199 | 273 | 10 | 2579_UP |
| Drug | AH6809; Down 200; 1uM; PC3; HT_HG-U133A | 1.53e-04 | 199 | 273 | 10 | 7075_DN | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A | DENND4A ACADSB VPS33A PDS5A PPIL2 UTY PLA2G3 OAS3 AHCYL2 UGGT2 | 1.53e-04 | 199 | 273 | 10 | 6002_DN |
| Drug | Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; HL60; HT_HG-U133A | ACADSB IRF4 PARP1 HROB PPIL2 RASAL2 BAHCC1 FOXN2 UBR4 GEMIN4 | 1.53e-04 | 199 | 273 | 10 | 2972_UP |
| Drug | Pentylenetetrazole [54-95-5]; Down 200; 29uM; MCF7; HT_HG-U133A | POGZ R3HCC1L WIPF2 HSPA2 RANGAP1 SLC4A2 GEMIN4 UGGT2 PKN1 TNKS2 | 1.59e-04 | 200 | 273 | 10 | 5508_DN |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.59e-04 | 200 | 273 | 10 | 2197_DN | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; HL60; HT_HG-U133A | 1.59e-04 | 200 | 273 | 10 | 2159_UP | |
| Disease | pulse pressure measurement | EPHB4 CLGN MYO1E ETFA ETFDH POGZ STEAP2 PNPT1 STXBP2 FER1L5 CLEC16A VCL NPNT ZFAT HEATR5A ACAD10 MSH5 CCDC141 DENND4C PLCD3 SPTBN4 EVA1C CCT6A FAM193A ZFHX4 ZNF827 EEPD1 KIAA1755 SORCS3 PRKCE XRCC6 | 3.60e-06 | 1392 | 266 | 31 | EFO_0005763 |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | AHCYL1 PABPC4 ETFA ETFDH DGKQ HNF4A ABCG5 LDLR RGS12 CELSR2 EEPD1 HACL1 MVK | 6.52e-06 | 315 | 266 | 13 | EFO_0004574, EFO_0004612 |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.24e-05 | 63 | 266 | 6 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.24e-05 | 63 | 266 | 6 | EFO_0022239 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | AHCYL1 PABPC4 ETFA ETFDH DGKQ HNF4A ABCG5 LDLR RGS12 CELSR2 EEPD1 MVK | 2.96e-05 | 312 | 266 | 12 | EFO_0004612, EFO_0010351 |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | HNF4A ABCG5 NOVA2 DMGDH LDLR RGS12 CELSR2 ZNF335 EEPD1 PCSK6 | 4.11e-05 | 225 | 266 | 10 | EFO_0008317, EFO_0020947 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | PABPC4 ETFA ETFDH DGKQ HNF4A HFM1 DMGDH LDLR RGS12 CELSR2 PCSK6 | 4.61e-05 | 276 | 266 | 11 | EFO_0004612, EFO_0020943 |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | PABPC4 ETFA ETFDH DGKQ HNF4A ABCG5 LDLR CELSR2 EEPD1 HACL1 RNF39 MVK | 5.09e-05 | 330 | 266 | 12 | EFO_0004529, EFO_0004612 |
| Disease | sexual dimorphism measurement | GDF5 RPN2 PABPC4 VPS33A ETFA ETFDH HNF4A PNPT1 BTN2A2 HROB PNPLA1 C11orf68 HERC1 WIPF2 RANGAP1 ZFAT NSD1 AIP LDLR GSS ADGRG6 ABCE1 ZNF335 PATJ | 7.19e-05 | 1106 | 266 | 24 | EFO_0021796 |
| Disease | free cholesterol to total lipids in small HDL percentage | 9.60e-05 | 51 | 266 | 5 | EFO_0022285 | |
| Disease | Bone Diseases, Developmental | 9.62e-05 | 27 | 266 | 4 | C0005941 | |
| Disease | serum selenium measurement | 1.16e-04 | 53 | 266 | 5 | EFO_0005266 | |
| Disease | Mouth Diseases | 1.50e-04 | 12 | 266 | 3 | C0026636 | |
| Disease | Antihypertensive use measurement | ETFA ETFDH NPNT CACNA1C SRBD1 CCDC141 GTF2I DNAJC11 SORCS3 PRKCE | 1.59e-04 | 265 | 266 | 10 | EFO_0009927 |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.68e-04 | 31 | 266 | 4 | DOID:3328 (biomarker_via_orthology) | |
| Disease | total cholesterol measurement, C-reactive protein measurement | 1.68e-04 | 31 | 266 | 4 | EFO_0004458, EFO_0004574 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | PABPC4 ETFA ETFDH DGKQ HNF4A RASAL2 LDLR CELSR2 EEPD1 PCSK6 HACL1 | 1.75e-04 | 321 | 266 | 11 | EFO_0004612, EFO_0004639 |
| Disease | mean corpuscular hemoglobin concentration | DENND4A HK1 STXBP4 PABPC4 ABCA7 AP3S1 C6orf118 UBTF VPS13A HFM1 KIF3C ZFAT ANK1 ACAD10 PABPC1 MYLK2 SLC4A2 PRR35 BRF1 PRKCE RPA1 PPP1R16A SP7 | 1.87e-04 | 1105 | 266 | 23 | EFO_0004528 |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.94e-04 | 13 | 266 | 3 | cv:C4082197 | |
| Disease | Sicca Syndrome | 1.94e-04 | 13 | 266 | 3 | C0086981 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 1.94e-04 | 13 | 266 | 3 | C0369183 | |
| Disease | Sjogren's Syndrome | 1.94e-04 | 13 | 266 | 3 | C1527336 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 1.94e-04 | 13 | 266 | 3 | C1261502 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 2.09e-04 | 60 | 266 | 5 | EFO_0022282 | |
| Disease | phospholipids:total lipids ratio | 2.34e-04 | 227 | 266 | 9 | EFO_0020946 | |
| Disease | Glutaric Aciduria IIB | 2.41e-04 | 3 | 266 | 2 | C1856403 | |
| Disease | Glutaric Aciduria IIC | 2.41e-04 | 3 | 266 | 2 | C1856405 | |
| Disease | Glutaric Aciduria IIA | 2.41e-04 | 3 | 266 | 2 | C1856401 | |
| Disease | multiple acyl-CoA dehydrogenase deficiency (is_implicated_in) | 2.41e-04 | 3 | 266 | 2 | DOID:0060358 (is_implicated_in) | |
| Disease | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 2.41e-04 | 3 | 266 | 2 | C0268596 | |
| Disease | MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY | 2.41e-04 | 3 | 266 | 2 | 231680 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 2.41e-04 | 3 | 266 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | multiple acyl-CoA dehydrogenase deficiency (implicated_via_orthology) | 2.41e-04 | 3 | 266 | 2 | DOID:0060358 (implicated_via_orthology) | |
| Disease | fascioliasis (biomarker_via_orthology) | 2.41e-04 | 3 | 266 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | Multiple acyl-CoA dehydrogenase deficiency | 2.41e-04 | 3 | 266 | 2 | cv:C0268596 | |
| Disease | Headache | 2.83e-04 | 64 | 266 | 5 | HP_0002315 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 2.83e-04 | 64 | 266 | 5 | EFO_0022253 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 3.04e-04 | 15 | 266 | 3 | DOID:13413 (biomarker_via_orthology) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.44e-04 | 144 | 266 | 7 | EFO_0004611, EFO_0020943 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.86e-04 | 243 | 266 | 9 | EFO_0004612, EFO_0020944 | |
| Disease | pain | 4.28e-04 | 196 | 266 | 8 | EFO_0003843 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.61e-04 | 303 | 266 | 10 | EFO_0004612, EFO_0020945 | |
| Disease | migraine without aura, susceptibility to, 4, systolic blood pressure | 4.80e-04 | 4 | 266 | 2 | EFO_0006335, MONDO_0011847 | |
| Disease | systolic blood pressure, response to cold pressor test | 4.80e-04 | 4 | 266 | 2 | EFO_0005404, EFO_0006335 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 5.11e-04 | 307 | 266 | 10 | EFO_0004612, EFO_0020946 | |
| Disease | intellectual disability (implicated_via_orthology) | 5.92e-04 | 75 | 266 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | asthma, response to diisocyanate | 6.46e-04 | 261 | 266 | 9 | EFO_0006995, MONDO_0004979 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.00e-04 | 264 | 266 | 9 | EFO_0008317, EFO_0020944 | |
| Disease | eye disease | 7.19e-04 | 45 | 266 | 4 | EFO_0003966 | |
| Disease | creatinine measurement | HNF4A PTPN3 ALMS1 ARID5B NLRC3 ABCG5 DENND5B DMGDH ZFAT KIF26B LAMA2 NSD1 SHH PRR22 ACAD10 LDLR RGS12 ARG2 CELSR2 KIAA1755 | 7.57e-04 | 995 | 266 | 20 | EFO_0004518 |
| Disease | dimethylglycine measurement | 7.82e-04 | 46 | 266 | 4 | EFO_0010476 | |
| Disease | 2-hydroxyoctanoate measurement | 7.95e-04 | 5 | 266 | 2 | EFO_0800192 | |
| Disease | Partial Fetal Alcohol Syndrome | 7.95e-04 | 5 | 266 | 2 | C3661483 | |
| Disease | Choledochal Cyst, Type I | 7.95e-04 | 5 | 266 | 2 | C0009439 | |
| Disease | Choledochal Cyst, Type II | 7.95e-04 | 5 | 266 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 7.95e-04 | 5 | 266 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 7.95e-04 | 5 | 266 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 7.95e-04 | 5 | 266 | 2 | C1257799 | |
| Disease | Choledochal Cyst | 7.95e-04 | 5 | 266 | 2 | C0008340 | |
| Disease | migraine disorder, HOMA-B | 7.95e-04 | 5 | 266 | 2 | EFO_0004469, MONDO_0005277 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 7.95e-04 | 5 | 266 | 2 | C0814154 | |
| Disease | non-high density lipoprotein cholesterol measurement | HK1 DGKQ HNF4A PTPN3 PDS5A HFM1 PLXNA3 NSD1 HEATR5A LDLR DENND4C CELSR2 EEPD1 ENTPD6 PRKCE RP1 | 8.21e-04 | 713 | 266 | 16 | EFO_0005689 |
| Disease | hemolysis | 8.49e-04 | 47 | 266 | 4 | EFO_0009473 | |
| Disease | fumarate measurement | 8.54e-04 | 21 | 266 | 3 | EFO_0010480 | |
| Disease | response to selective serotonin reuptake inhibitor | 8.89e-04 | 82 | 266 | 5 | EFO_0005658 | |
| Disease | retinal vasculature measurement | HK1 IRF4 NCKAP5 PTK2B TJP2 CACNA1C LAMA2 SHH EYS SH3PXD2A DNAJC11 PRKCE PATJ | 9.10e-04 | 517 | 266 | 13 | EFO_0010554 |
| Disease | myeloid white cell count | MYO1E IRF4 HNF4A ABCA7 PTK2B BBX HFM1 KIF3C WIPF2 RASAL2 PLA2G3 ZNF316 MACROH2A1 PRX KIAA1755 PRKCE RP1 ATP1A3 TNKS2 | 9.23e-04 | 937 | 266 | 19 | EFO_0007988 |
| Disease | serum IgG glycosylation measurement | MTSS1 MDGA2 PNPT1 SLC38A10 SBF1 ALDH1L2 ARID5B ST6GAL1 EYS BRD2 LPO LYG1 EPHA4 | 1.01e-03 | 523 | 266 | 13 | EFO_0005193 |
| Disease | Sarcosine measurement | 1.12e-03 | 23 | 266 | 3 | EFO_0021668 | |
| Disease | electrocardiography | MEF2D PTPN3 NALF1 VCL NOVA2 CACNA1C SHH E2F6 CCDC141 GSS SH3PXD2B SH3PXD2A KIAA1755 | 1.14e-03 | 530 | 266 | 13 | EFO_0004327 |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 1.19e-03 | 6 | 266 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | Congenital cataract | 1.19e-03 | 6 | 266 | 2 | C0009691 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 1.19e-03 | 6 | 266 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | Alcohol Related Birth Defect | 1.19e-03 | 6 | 266 | 2 | C3146244 | |
| Disease | Anhedonia | 1.27e-03 | 24 | 266 | 3 | C0178417 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.29e-03 | 132 | 266 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | left ventricular diastolic function measurement | 1.43e-03 | 54 | 266 | 4 | EFO_0008204 | |
| Disease | mental development measurement | 1.44e-03 | 25 | 266 | 3 | EFO_0008230 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.53e-03 | 55 | 266 | 4 | EFO_0022234 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.54e-03 | 239 | 266 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | Degenerative polyarthritis | 1.56e-03 | 93 | 266 | 5 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 1.56e-03 | 93 | 266 | 5 | C0086743 | |
| Disease | brain measurement, neuroimaging measurement | GDF5 NCKAP5 TTC34 BAHCC1 ANK3 SLC27A6 KIF26B MYLK2 ZBTB32 SH3PXD2A ENTPD6 KIAA1755 EPHA4 | 1.58e-03 | 550 | 266 | 13 | EFO_0004346, EFO_0004464 |
| Disease | Common Migraine | 1.65e-03 | 7 | 266 | 2 | C0338480 | |
| Disease | LDL cholesterol change measurement | 1.65e-03 | 7 | 266 | 2 | EFO_0007804 | |
| Disease | common variable immunodeficiency | 1.65e-03 | 7 | 266 | 2 | MONDO_0015517 | |
| Disease | migraine without aura, susceptibility to, 4, diastolic blood pressure | 1.65e-03 | 7 | 266 | 2 | EFO_0006336, MONDO_0011847 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.87e-03 | 58 | 266 | 4 | EFO_0022338 | |
| Disease | Autosomal Dominant Parkinsonism | 2.01e-03 | 28 | 266 | 3 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 2.01e-03 | 28 | 266 | 3 | C0752097 | |
| Disease | Parkinsonism, Experimental | 2.01e-03 | 28 | 266 | 3 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 2.01e-03 | 28 | 266 | 3 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 2.01e-03 | 28 | 266 | 3 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 2.01e-03 | 28 | 266 | 3 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 2.01e-03 | 28 | 266 | 3 | C1868675 | |
| Disease | aortic measurement | 2.09e-03 | 251 | 266 | 8 | EFO_0020865 | |
| Disease | Familial hyperinsulinism | 2.19e-03 | 8 | 266 | 2 | cv:C3888018 | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 2.19e-03 | 8 | 266 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | asymmetrical dimethylarginine measurement | 2.19e-03 | 8 | 266 | 2 | EFO_0006522 | |
| Disease | hypoglycemia (is_implicated_in) | 2.19e-03 | 8 | 266 | 2 | DOID:9993 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAGIGKDFKENPNLR | 651 | Q13523 | |
| KPSVKGRAQLGVQAF | 426 | P40227 | |
| KTILEARSGLGPIKA | 226 | Q96PM9 | |
| TGAGLEPKSAQDKAL | 646 | P04920 | |
| KAKVGTTLERAPGQR | 1731 | Q9P281 | |
| KRKAVAAASKGPGVL | 2136 | Q9P281 | |
| GAVSLRAAIRKPGKV | 21 | Q63HQ2 | |
| LEGISLGPGASLKRK | 81 | Q9H0I2 | |
| DKPAGKGLITIAAQE | 136 | Q96FN4 | |
| GPEAVKGQTLLAVAK | 331 | P02750 | |
| VAVIGAPFSQGQKRK | 26 | P78540 | |
| GEFGEKRKNSILNPI | 691 | P13569 | |
| AGGTLDDKPKEQLQR | 846 | Q8WY36 | |
| QPGKGIQLKARAFEL | 1131 | Q7Z408 | |
| ADKKPEQGQRVSGIL | 471 | Q9UKF6 | |
| QGLVAAALEKLEKGP | 406 | P07510 | |
| KTGLFQDVGPQRKTL | 751 | Q86SQ4 | |
| AELSVKAGFPKGVIN | 631 | Q3SY69 | |
| VLLDKGAKPNSRALN | 356 | P16157 | |
| LELRKKNGPLEVAGA | 246 | O75367 | |
| ADKNERIGKSGNIPA | 716 | Q9UL18 | |
| LKISVAPGLADQKTG | 1121 | Q8TCU4 | |
| GPTVRKFAKVALAAG | 841 | C9J069 | |
| VFVNPKSGGLKGRDL | 591 | P52824 | |
| KSRLAFGKPLVEQGT | 941 | Q6JQN1 | |
| IGKPENKLGLRASST | 246 | P45954 | |
| SNLKRVTLELGGKSP | 261 | P00352 | |
| PLKDTAAGQNGKVRL | 471 | Q86SJ2 | |
| EVKRLQKSLGVPGDA | 911 | O60306 | |
| SREGALKAAPGSIKQ | 566 | Q8N283 | |
| VVRLDKGNFAGAKLP | 2171 | Q9HCU4 | |
| KLEKSEAGLAGAPAR | 146 | Q92572 | |
| VGSDIDFRPKLVNGK | 81 | Q13111 | |
| LRQLSAAAKVKAPSG | 6 | P78312 | |
| KKDAPRNGSGVALER | 546 | Q7L9B9 | |
| GLADKLNKSRPLGAE | 311 | Q2TAZ0 | |
| KTFVGGPLKANAENR | 1371 | Q8IXJ9 | |
| KRKLATALALVGDPA | 1931 | Q8IZY2 | |
| VAKSLRNIAVGKDPL | 101 | O00170 | |
| EAGPKDVLAGSKRLS | 71 | Q8NE62 | |
| SGPLDKEDTGRQKLI | 1591 | Q7Z401 | |
| VPKARRGAVLLKTGD | 21 | Q7Z5L2 | |
| QGKPLALKVFVAGRN | 176 | P46060 | |
| QPLDKVRDLAGSGTK | 2291 | Q96L73 | |
| NPSNGEKLDGRSLIK | 76 | Q13356 | |
| KPARAAPKIANGKAA | 201 | Q14978 | |
| AQDGPGSLTKAKVLI | 321 | Q9Y5G6 | |
| IDPKTGLIRVKGNLD | 296 | O14917 | |
| PINKGRKRAAVGQES | 1291 | Q29RF7 | |
| GNISKDLGLDPRKLA | 46 | Q9Y5G5 | |
| ALKLGQEGKVPLQSA | 521 | Q32P28 | |
| EASKAIRKQLKGGFP | 86 | P26045 | |
| GSKPQIAEIIRSFKG | 226 | Q15397 | |
| EVVAPRGKSGAALSK | 491 | P09874 | |
| RNAKQPLLIIGKGAA | 211 | Q9UJ83 | |
| PSLRKSGVGNIFIKN | 91 | P11940 | |
| QDFPSVVLVGLGKKA | 91 | P28838 | |
| GALGSIKAIPRFNQK | 421 | P11182 | |
| DPSLRKSGVGNVFIK | 81 | Q5JQF8 | |
| KVAGALLRAIFKGSP | 41 | Q9NVI1 | |
| PSLRKSGVGNVFIKN | 91 | Q13310 | |
| LPKGAAIKDGRLQSG | 416 | Q8TEW8 | |
| GVPQGVSLKVKLNRA | 356 | Q9NVH1 | |
| AEPKVNRGNAGVKRS | 86 | O60812 | |
| KARLLIGLSVGDKNP | 2211 | Q14667 | |
| QKLEAFPLKTGTRQG | 646 | O00370 | |
| FRSVLGGKKKLPAEN | 981 | Q15746 | |
| EAVLQSPGLSGKVKR | 851 | Q13045 | |
| QGTRPGLAKAEAKER | 36 | P43026 | |
| VFARGKQRKSLDPGL | 391 | Q674X7 | |
| KNKSIIAPGRLVGLN | 2531 | Q5T1H1 | |
| AEPKVNRGNAGVKRS | 86 | B2RXH8 | |
| IGPQGAKALADALKI | 706 | Q7RTR2 | |
| VKRKLEGARSPLNGD | 161 | Q96JK9 | |
| LTRKRPGAEATGKVN | 146 | P54760 | |
| RIVPEGAKKGAKQLT | 126 | Q15306 | |
| SAAKAPGGKAARLVL | 456 | Q6UXI9 | |
| QVLPAQSLAKGKGRT | 226 | Q5JYT7 | |
| AEPKVNRGNAGVKRS | 86 | B7ZW38 | |
| KLAPTSQKGGLDRFQ | 676 | P46020 | |
| SGQRRKKLIAGAESP | 316 | Q02156 | |
| LRAVNKVKDTPGLGK | 436 | Q2KJY2 | |
| LGLGNTSNKKLPERV | 4166 | Q15751 | |
| LNTEIRDVGPLSKKG | 166 | P54764 | |
| GLSDPGKIKRLRSQV | 301 | P41235 | |
| GAGGERPKEASKINL | 281 | O14782 | |
| GGSTRIPKIQKLLQD | 341 | P54652 | |
| DGKTVDGPGRLAKQA | 311 | P29122 | |
| LKGKNLIPAAAGSSR | 1146 | P51805 | |
| LVKPVKAALDLAAGN | 61 | O15428 | |
| AKKGRGDIQPQLDSA | 151 | O43312 | |
| PEELANGSRVGKLAK | 36 | Q9Y5G3 | |
| PRVGKKAAEGQAAAR | 126 | Q9H1R3 | |
| LIRKGAAANDGKLQP | 56 | Q8IXQ8 | |
| DGGIDPLVRGLLAKK | 506 | P22079 | |
| VGGDIAKQLPQEAKR | 1506 | Q96JB1 | |
| TIDKDRIIDAGPKGN | 1121 | O96028 | |
| NVGVAEVKKSFLGPL | 76 | Q8N8W4 | |
| RKVDQGGLGARAKAP | 871 | Q9UJF2 | |
| LPAQQREGSVLAKKA | 186 | Q8N3J3 | |
| EATKLATGPRGLLKE | 1951 | P24043 | |
| AEPKVNRGNAGVKRS | 86 | P0DMR1 | |
| QKFTEPGAGLRALQK | 126 | Q9Y546 | |
| QKLDLAGTLPGSKRQ | 1196 | P46013 | |
| PASGDEGIKVLKQRA | 2636 | P46013 | |
| EGAKASKQGVLDLPN | 911 | Q6IE36 | |
| TGARIQISKKGEFLP | 436 | Q9UNW9 | |
| QGAPGRKLSKIATLL | 141 | Q8TAK6 | |
| IDRGSLNPGKQLFEK | 281 | P19367 | |
| LAFKGTKNRPGSALE | 96 | P31930 | |
| AKAQPIKGARRAPDS | 296 | Q9NQS5 | |
| AAKRQKAQVTGDPGA | 571 | Q86VI3 | |
| KAENGLGSPAIKSIR | 111 | Q7Z553 | |
| PSLRKSGVGNIFVKN | 91 | Q9H361 | |
| PVKANDNIRIEAGGK | 1681 | Q96RW7 | |
| GDKAQLKGVRSDPLQ | 1331 | O95248 | |
| DPAKKATRVSLQGRG | 186 | P29475 | |
| DLSVKRAPAKGPQAL | 466 | P0CG20 | |
| NGLGSLKAVTEIPAK | 256 | A2PYH4 | |
| AILNKKEERGGLAAP | 16 | P78367 | |
| TVDGKPLGRISIKQF | 11 | P0DN37 | |
| DKFDGSRQPVLAIKG | 366 | P27694 | |
| NLEGQRKISPGSIKD | 66 | A4FU69 | |
| DPSGSKVLRKDGILV | 291 | P58658 | |
| IQKDGAPKATFERGL | 221 | Q16134 | |
| IPKAAKGTVGSILDR | 176 | P61221 | |
| SPALKARLEAAIKGN | 1996 | Q86XA9 | |
| GAEKLRKLQPSLNSG | 486 | O95838 | |
| LTGRGAPVKEKSQQL | 751 | Q6ZP82 | |
| RLPQDLKVSTDKEGG | 1176 | Q6ZP82 | |
| KDRGGDISQKTVLPL | 1991 | Q13936 | |
| ARPGVKKVALVITDG | 891 | Q2UY09 | |
| SAPGGILDLNKVATK | 81 | O75461 | |
| SNAPRVKAKIIAEGA | 391 | P00367 | |
| GLRKKNLSPGAVESD | 166 | P53621 | |
| TGGLEPAKINITAKA | 386 | Q7Z7M9 | |
| LKGQGNPVELITKAR | 1386 | O15360 | |
| KTNGALEDAPLKGLE | 381 | Q12934 | |
| ADGKGVLPRKLNFQV | 511 | P06756 | |
| AQLKALGQRPVKTAD | 316 | Q5T5N4 | |
| AINTAPRNIGKDGKF | 1191 | Q6ZUT9 | |
| DNILSGPKIDVLKSG | 1351 | Q5VZ89 | |
| IRRGNPGSFQKKVEA | 156 | Q9H222 | |
| DDSPALKEKRVGGVQ | 91 | P17174 | |
| ENGLLTPTLKAKRGE | 651 | Q9ULC5 | |
| GAKIDAKTRDGLTPL | 291 | Q12955 | |
| KGKSIGRAPEASLQD | 356 | P41597 | |
| RAALVLGGPKFASKT | 26 | Q6GMR7 | |
| VKGRKPAALGEAQPT | 121 | P13232 | |
| GVAGPQARKVLQKLT | 631 | Q9UI17 | |
| IAGVLSRKSPGDKIL | 86 | Q8N1E2 | |
| AVFKGGQDNIPVLKR | 421 | P13637 | |
| KRAETPGAEKIAGLS | 11 | P32314 | |
| REGSKRLDIPLNSKG | 2986 | Q8NDH2 | |
| NTKGIGLLFPRQAEK | 3301 | Q8NDH2 | |
| TEIDPAKGGRKQALL | 5891 | Q8NDH2 | |
| IGPKGIRQLTSQDAK | 281 | Q14289 | |
| LAGTKKVQQELSRPG | 301 | P48637 | |
| RENKLASLPGGVLKT | 406 | Q6ZVF9 | |
| GEALGLKQAVKVPFA | 746 | P78347 | |
| VAGLGSKPLIEIKAQ | 146 | Q8WVV5 | |
| RKKAAATGLPEGPAV | 161 | Q8N1S5 | |
| GQKDAAPRAAGTVKE | 836 | Q9HBR0 | |
| LKDSPAGRGLSKAAV | 571 | Q3KP66 | |
| SNAPRVKAKIIAEGA | 391 | P49448 | |
| LTAPTGKAAGLLRQK | 536 | Q8NG08 | |
| GQALKLKSIVRGDAP | 451 | Q5VVW2 | |
| AALRAAGLTVKPSGK | 491 | Q9BV36 | |
| IAKDAKGNEGLVPRT | 191 | O15259 | |
| SVPQGLLKAARKSGQ | 26 | Q9H9A6 | |
| RKPDLRVITSQAGKG | 266 | Q14814 | |
| NGEPGTRVVAKDGLK | 11 | O95997 | |
| GDDIAGLVPRKVKSA | 316 | Q9HAU5 | |
| GGSSRIPKLQQLIKD | 336 | Q0VDF9 | |
| PRNGFRSKLKEVGQA | 766 | Q92833 | |
| RLGAAAPRVLKTVKG | 46 | Q9Y6K5 | |
| SLGAPKKREIGQRDK | 786 | P56715 | |
| QAVLKVPGSEARLKA | 241 | Q8NGH7 | |
| QAVLKVPGNEARLKA | 241 | Q8NGH6 | |
| ILSLPKSQAGEGRRK | 221 | Q8NGI6 | |
| AGLPDKLVARGKEVS | 761 | O43196 | |
| KSEPGQRSKVDIGLL | 786 | Q9NXL9 | |
| AAIGPEAAKIARKQL | 206 | Q9GZR2 | |
| GPLTKGIFRQSANVK | 391 | Q9P2F6 | |
| KNPVTVIRGLAGALK | 911 | O14607 | |
| AGRVENFGKRKPLLQ | 1136 | Q6WKZ4 | |
| GEAKPRGLTKADIEQ | 431 | Q9H0F5 | |
| KRAQGEKPLAGAKIV | 216 | Q96HN2 | |
| NRGREPEASGLKALK | 426 | Q14684 | |
| GTKLVKDLSPGDRVL | 211 | Q15465 | |
| DGAKVFSKQPGRIQR | 391 | P61011 | |
| KILGLAPSRAATKQA | 211 | Q9UM00 | |
| KILQVRAASAPAKGT | 296 | Q13428 | |
| ATAGLRLLPGEKAQK | 181 | O75354 | |
| ILSEKEALIKPAGRG | 1906 | A0AVI2 | |
| AGEKKGPNRNRVFIS | 91 | Q9P2K5 | |
| GRGQLVKALKSAAPE | 1891 | O14513 | |
| ISLRKRAQGEKPLAG | 131 | O43865 | |
| RAQGEKPLAGAKIVG | 136 | O43865 | |
| GSRPLAKGSREEVKA | 156 | Q9UPU3 | |
| PKDLRIDTKRASGAG | 236 | Q9UGC7 | |
| ELARKGTGKEQAPLE | 1106 | Q6P1X5 | |
| EGFGKTAAIIQLAPK | 131 | Q5VZ19 | |
| ALIESIEGKQGKPRL | 211 | P49821 | |
| GKNLLPRVAAKLEVA | 116 | P13804 | |
| TGAAKAVGKVIPELN | 211 | P04406 | |
| RDGGKVAQLTNFPKV | 476 | Q7Z3K3 | |
| QFDAIPGKKGTRVLI | 206 | Q8TE76 | |
| GERPRKEAASQGLLK | 51 | Q96I34 | |
| GLAAIQLPKKAGDIT | 126 | P21815 | |
| QTLGSLRGLAKAKPE | 76 | P15907 | |
| TFLPNGINGIKDARK | 16 | Q8NFT2 | |
| RKTRGVPLSEAGNVK | 591 | Q8TF30 | |
| EKLLVFTAAGVKPQG | 151 | Q96T60 | |
| GAKNVLRLLSAAKAP | 231 | Q16512 | |
| NETGLLEKGLRPKDS | 1976 | Q9P2P6 | |
| APLRDKGNSVGVKPD | 141 | Q8NHU6 | |
| NKGITALQADIKLPG | 551 | Q8TCS8 | |
| DGRLKPGDQLVSVNK | 61 | Q6ZWJ1 | |
| LEESPAGARKKRAAG | 121 | Q9NZ20 | |
| GKSGLIPIRNVTEAK | 941 | Q8N5C6 | |
| IKDGERATALAGTKP | 241 | Q86UX6 | |
| SLDINKLPGEKLGRV | 651 | P25440 | |
| VDVKAPGAKLDGARL | 2286 | Q8IVF2 | |
| LVIAGKKARAVSPLD | 1021 | Q14865 | |
| KENQVPGDRGLVLKS | 101 | O14967 | |
| VGKDKGGEQRLISLP | 6 | Q9NRG0 | |
| LENQDKGGERPKISL | 296 | Q2KHT3 | |
| LQVAKVSPRAKEGGR | 196 | Q9H3H3 | |
| AGKAKAPKTARALAL | 266 | Q8IZ63 | |
| PDGKLVTVGRDLKAS | 206 | Q9HCU5 | |
| QRILAPGKEGLKNFA | 6 | Q9P2U8 | |
| PGAKRILELDQFKGQ | 111 | P12956 | |
| AKRKLSGLEQPQGAL | 356 | Q6RFH5 | |
| NSLEVKAKPASGLDG | 3541 | Q86UP3 | |
| GKEARQLSGAKKPII | 186 | Q9P243 | |
| GNELEKGLIPNKSRA | 651 | Q9UDY2 | |
| REEAKDSKQNGGLIP | 2786 | Q96RL7 | |
| DVKLTAGLKPGQDAN | 786 | Q7Z392 | |
| IKGENGKNARDPRLS | 1151 | O14924 | |
| QVKLRKGSAPGNLSL | 2346 | Q99973 | |
| AGKNGTLKPGDRIVE | 1196 | O75970 | |
| LSALGIQEKTGSKPR | 31 | A6NGZ8 | |
| VGLSSLGAQVPDAKK | 56 | P04844 | |
| LGAAAAGLRKKPIHS | 281 | Q8TDD2 | |
| IFPVDLQKKAGRGLG | 1531 | Q8NI35 | |
| NGKVDLSLPNIGIKR | 46 | Q03426 | |
| GKKLPAARSEDGRAL | 481 | Q8N3E9 | |
| AGIRGTPKVRAKKDA | 726 | Q5TCZ1 | |
| RPAKSQDKSLLDGEG | 671 | A1X283 | |
| LPKARVGAEAEAKGA | 966 | Q9BXM0 | |
| RLGDAKPRGLTKADI | 346 | Q7L0R7 | |
| AIVAKTFKGRGIPNI | 241 | Q9H0I9 | |
| KNKAGIEARAGPRLI | 521 | Q15833 | |
| GRIQADKAKGPGLIL | 66 | Q8TAV4 | |
| QGKGDSPEARALAKQ | 451 | P18206 | |
| GQAPEGLKVKLSDAS | 1091 | O15014 | |
| EASLRKDPRNAGLKG | 1686 | Q9HCK1 | |
| PIRGDLVKGKATLAD | 2311 | Q9H254 | |
| ELENSRPKAKGGLAS | 331 | Q92994 | |
| KNRDGNTPLDLVKDG | 621 | Q9H2K2 | |
| KLGQDLLRDATNGPK | 26 | P98182 | |
| DALKPQEGKGSVLRR | 631 | Q17R98 | |
| RGGDAKSPVLQEKGL | 106 | A6NFI3 | |
| AAGKVSPKQRELAGN | 471 | Q7RTT9 | |
| RGPQLAAKKAALVAG | 1431 | A6NGW2 | |
| AAKKAALVAGVVRPA | 1436 | A6NGW2 | |
| SKEKRLQAPVGQRGA | 191 | Q9Y2Y4 | |
| NLEKAGLLKPQTGGR | 446 | Q96AX1 | |
| GVLKLRPVGAKDGSE | 91 | Q8TF74 | |
| RPVGAKDGSENLAGK | 96 | Q8TF74 | |
| KDGSENLAGKPALQI | 101 | Q8TF74 | |
| ISVTGGAKNFALKPR | 146 | Q7Z2W7 | |
| RGLQFTLGTKNKPAV | 1106 | Q9NYU1 | |
| AALKAQSERKPGGER | 461 | P17480 | |
| VKKGEPGLLISRVNA | 416 | Q9Y2P4 | |
| VAPGGATRLTDKAVK | 5071 | Q5T4S7 | |
| PVAAAAAAAGKKGRL | 271 | Q9H4Z2 | |
| ILGVSPTANKGKIRD | 66 | Q96DA6 | |
| LKKGDVPGAARDLQS | 351 | A8MYJ7 | |
| ELGPQAVGAVKALKA | 81 | Q96QR1 | |
| LGDREAKKQGPVATG | 1006 | Q9BVV6 | |
| EAIPGEGRKAAKVNA | 16 | Q9H2S5 | |
| DKLPSNVLRGGQEVK | 91 | Q9BYP7 | |
| SLPGKNKVLAGILRS | 491 | P57678 | |
| ALGDVAGRGNEKKPS | 771 | P01130 | |
| AGRGNEKKPSSVRAL | 776 | P01130 | |
| QGFGDLAVLKPSNKV | 901 | Q12965 | |
| DRGKALFLGNSAKPV | 151 | B1AL88 | |
| VGLATRKLGNLAKPT | 26 | P02689 |